# EDGAR Filing Document

**Accession Number:** 0001120970
**File Stem:** 0001437749-25-026942
**Filing Date:** 2025-8
**Character Count:** 231994
**Document Hash:** 43a8141d5346165a5c28488f0848b783
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-026942.hdr.sgml**: 20250814

**ACCESSION NUMBER**: 0001437749-25-026942

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 99

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250814

**DATE AS OF CHANGE**: 20250814

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Comstock Inc.
- **CENTRAL INDEX KEY:** 0001120970
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL ORGANIC CHEMICALS [2860]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 650955118
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35200
- **FILM NUMBER:** 251219471

**BUSINESS ADDRESS:**
- **STREET 1:** 117 AMERICAN FLAT ROAD
- **STREET 2:** PO BOX 1118
- **CITY:** VIRGINIA CITY,
- **STATE:** NV
- **ZIP:** 89440
- **BUSINESS PHONE:** 775-847-5272

**MAIL ADDRESS:**
- **STREET 1:** 117 AMERICAN FLAT ROAD
- **STREET 2:** PO BOX 1118
- **CITY:** VIRGINIA CITY,
- **STATE:** NV
- **ZIP:** 89440

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Comstock Mining Inc.
- **DATE OF NAME CHANGE:** 20100720

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GOLDSPRING INC
- **DATE OF NAME CHANGE:** 20040730

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GOLDSPRING
- **DATE OF NAME CHANGE:** 20030821

?xml version='1.0' encoding='ASCII'? lode20250630_10q.htm

[**Table of Contents**](#toc)

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

------

**FORM 10-Q**

------

**☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**FOR THE QUARTERLY PERIOD ENDED June 30, 2025**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**FOR THE TRANSITION PERIOD FROM ______ TO ______.**

C**OMMISSION FILE NO.: 001-35200**

![logo01.jpg](logo01.jpg) <br>

**COMSTOCK INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Nevada** |  | **65-0955118** |
| (State or other jurisdiction of<br> incorporation or organization) |  | (I.R.S. Employer<br> Identification No.) |
| **117 American Flat Road, Virginia City, NV** |  | **89440** |
| (Address of principal executive offices) |  | (Zip Code) |
|  | **(775) 847-5272** |  |
|  | (Registrant's telephone number) |  |
|  | Securities registered pursuant to Section 12(b) of the Act: |  |
| Title of each class | Trading Symbol | Name of each exchange on which registered |
| Common Stock, par value $0.000666 per share | LODE | NYSE American |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Securities registered pursuant to Section 12(g) of the Acts: None |  |  |  |  |
| Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. | Yes | ☒ | No | ☐ |
| Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the prior 12 months (or for such shorter period that the registrant was required to submit such files). | Yes | ☒ | No | ☐ |
| Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. |  |  |  |  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer  | ☐ | Emerging growth company | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |  |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |  |  |  | ☐ |
| Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). | Yes | ☐ | No | ☒ |
| The number of shares outstanding of Common Stock, $0.000666 par value per share, on August 13, 2025 was 35,930,913. |  |  |  |  |

---

------

[**Table of Contents**](#toc)

This page intentionally left blank.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2

------

[**Table of Contents**](#toc)

**COMSTOCK INC.**

**FORM 10-Q**

**FOR THE QUARTERLY PERIODS ENDED June 30, 2025 and 2024**

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
| [<u>PART I</u> <u>–</u> <u>FINANCIAL INFORMATION</u>](#partone) | [<u>PART I</u> <u>–</u> <u>FINANCIAL INFORMATION</u>](#partone) |
| [<u>Item 1. Financial Statements.</u>](#finstmts) |  |
| [<u>CONDENSED CONSOLIDATED BALANCE SHEETS</u>](#bs) | [5](#bs) |
| [<u>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</u>](#ops) | [7](#ops) |
| [<u>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</u>](#se) | [8](#se) |
| [<u>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</u>](#cf) | [9](#cf) |
| [<u>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>](#notes) | [11](#notes) |
| [<u>Item 2. Management</u><u>'</u><u>s Discussion and Analysis of Financial Condition and Results of Operations.</u>](#mda) | [33](#mda) |
| [<u>Item 3. Quantitative and Qualitative Disclosures About Market Risk</u>.](#quant) | [41](#quant) |
| [<u>Item 4. Controls and Procedures.</u>](#controls) | [41](#controls) |
| [<u>PART II</u> <u>–</u> <u>OTHER INFORMATION</u>](#parttwo) | [<u>PART II</u> <u>–</u> <u>OTHER INFORMATION</u>](#parttwo) |
| [<u>Item 1. Legal Proceedings.</u>](#legal) | [42](#legal) |
| [<u>Item 1A. Risk Factors.</u>](#risk) | [42](#risk) |
| [<u>Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</u>](#unregistered) | [42](#unregistered) |
| [<u>Item 3. Defaults Upon Senior Securities.</u>](#defaults) | [42](#defaults) |
| [<u>Item 4. Mine Safety Disclosures.</u>](#mine) | [42](#mine) |
| [<u>Item 5. Other Information.</u>](#otherinfo) | [42](#otherinfo) |
| [<u>Item 6. Exhibits.</u>](#exhibits) | [43](#exhibits) |
| [<u>Signatures</u>](#sigs) | [44](#sigs) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3

------

[**Table of Contents**](#toc)

**Cautionary Notice Regarding Forward-Looking Statements**

*Certain statements contained in this quarterly report on Form 10-Q are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words* "*believe,*" "*expect,*" "*anticipate,*" "*estimate,*" "*project,*" "*plan,*" "*should,*" "*intend,*" "*may,*" "*will,*" "*would,*" "*potential*" *and similar expressions identify forward-looking statements but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: future market conditions; future explorations or acquisitions; divestitures, spin-offs or similar distribution transactions, future changes in our research, development and exploration activities; future financial, natural, and social gains; future prices and sales of, and demand for, our products and services; land entitlements and uses; permits; production capacity and operations; operating and overhead costs; future capital expenditures and their impact on us; operational and management changes (including changes in the Board of Directors); changes in business strategies, planning and tactics; future employment and contributions of personnel, including consultants; future land and asset sales; investments, acquisitions, divestitures, spin-offs or similar distribution transactions, joint ventures, strategic alliances, business combinations, operational, tax, financial and restructuring initiatives, including the nature, timing and accounting for restructuring charges, derivative assets and liabilities and the impact thereof; contingencies; litigation, administrative or arbitration proceedings; environmental compliance and changes in the regulatory environment; offerings, limitations on sales or offering of equity or debt securities, including asset sales and associated costs; business opportunities, growth rates, future capital needs, revenues, variable costs, throughput rates, operating expenses, debt levels, cash flows, margins, taxes and earnings.*

*These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical and current trends, current conditions, possible future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees, representations or warranties and are subject to risks and uncertainties, many of which are unforeseeable and beyond our control and could cause actual results, developments and business decisions to differ materially from those contemplated by such forward-looking statements. Some of those risks and uncertainties include the risk factors set forth in this report and our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and the following: adverse effects of climate changes or natural disasters; adverse effects of global or regional pandemic disease spread or other crises; global economic and capital market uncertainties; difficulties involved in developing renewable, decarbonizing and/or clean energy technologies, hazards and uncertainties associated with hazardous material and metal recycling, processing or mining and mineral extraction activities, the speculative nature of gold or mineral exploration, and aluminum, cadmium, copper, silica, silver, steel, and other metal and materials recycling, including risks of diminishing quantities or grades of qualified resources; operational or technical difficulties in connection with exploration, metal recycling, material processing or mining activities; costs, hazards and uncertainties associated with precious and other metal based activities, including environmentally friendly and economically enhancing, novel clean mining and processing technologies, precious metal exploration, resource development, economic feasibility assessment, environmental reclamations and historical restorations and cash generating mineral production; contests over our title to properties; potential dilution to our stockholders from our stock issuances, recapitalization and balance sheet restructuring activities; potential inability to comply with applicable government regulations or law; adoption of or changes in legislation or regulations adversely affecting our businesses; permitting constraints or delays; challenges to, or potential inability to, achieve the benefits of business opportunities, including research and development stage activities that may be presented to, or pursued by, us, including those involving quantum computing and material science based artificial intelligence supported advanced materials development and development services, development of cellulosic technology in bio-fuels and related material production; commercialization of cellulosic technology in bio-fuels; ability to successfully identify, finance, complete and integrate acquisitions, divestitures, spin-offs or similar distribution transactions, joint ventures, strategic alliances, collaborative research and development agreement, business combinations, asset and equity investment sales, and investments that we may be party to in the future; changes in the United States or other monetary or fiscal policies or regulations; interruptions in our production capabilities due to capital constraints; equipment failures; fluctuation of prices for gold or certain other commodities (such aluminum, cadmium, copper, silica, silver, steel, and other metal and materials, cyanide, water, diesel, gasoline and alternative fuels and electricity); changes in generally accepted accounting principles; adverse effects of war, mass shooting, terrorism and geopolitical events; potential inability to implement our business strategies; potential inability to grow revenues; potential inability to attract and retain key personnel; interruptions in delivery of critical supplies, equipment and raw materials due to credit or other limitations imposed by vendors; assertion of claims, lawsuits and proceedings against us; potential inability to satisfy debt and lease obligations; potential inability to maintain an effective system of internal controls over financial reporting; potential inability or failure to timely file periodic reports with the Securities and Exchange Commission; potential inability to list our securities on any securities exchange or market or maintain the listing of our securities; and work stoppages or other labor difficulties. Occurrence of such events or circumstances could have a material adverse effect on our business, financial condition, results of operations or cash flows, or the market price of our securities. All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events, or otherwise.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4

------

[**Table of Contents**](#toc)

**PART 1 - FINANCIAL INFORMATION**

**Item 1. Financial Statements**

**COMSTOCK INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(UNAUDITED)** 

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***June 30, 2025*** |  | ***December 31, 2024*** |  |
| ASSETS |  |  |  |  |
| *Current Assets:* |  | |  | |
| Cash and cash equivalents | $18587742 |  | $954271 |  |
| Accounts receivable | 3221544 |  | 2419671 |  |
| Derivative assets | 617167 |  | 1529850 |  |
| Assets held for sale - land and mineral rights and properties |  |  | 7058933 |  |
| Prepaid expenses and other current assets | 566490 |  | 595320 |  |
| Total current assets | 22992943 |  | 12558045 |  |
| *Non-current Assets:* |  | |  | |
| Investments | 40318770 |  | 38885998 |  |
| Mineral rights and properties | 11980716 |  | 11250121 |  |
| Properties, plant and equipment, net | 27262260 |  | 8605094 |  |
| Deposits | 592500 |  | 411268 |  |
| Reclamation bond deposit | 3623302 |  | 3259514 |  |
| Notes receivable | 3230291 |  | 2430291 |  |
| Intangible assets, net | 26163016 |  | 5859152 |  |
| Finance lease - right of use asset, net | 3062541 |  | 3088188 |  |
| Operating lease - right of use asset, net | 7982457 |  | 4650862 |  |
| Other assets | 1008161 |  | 311348 |  |
| Total non-current assets | 125224014 |  | 78751836 |  |
| TOTAL ASSETS | $148216957 |  | $91309881 |  |

---

*The accompanying notes to the Condensed Consolidated Financial Statements are an integral part of these statements*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5

------

[**Table of Contents**](#toc)

**COMSTOCK INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS (Continued)**

**(UNAUDITED)** 

---

| | | |
|:---|:---|:---|
|  | ***June 30, 2025*** | ***December 31, 2024*** |
| LIABILITIES AND STOCKHOLDERS' EQUITY |  |  |
| *Current Liabilities:* |  |  |
| Accounts payable | $4068736 | $2853263 |
| Accrued expenses and other liabilities (Note 7) | 4291849 | 4518497 |
| Deferred revenue (Note 14) | 1440194 | 151939 |
| Derivative liabilities (Note 12) | 3777000 |  |
| Finance lease - right of use lease liability |  | 490075 |
| Debt, net | 1783064 | 97593 |
| Total current liabilities | 15360843 | 8111367 |
| *Long-term Liabilities:* |  |  |
| Reclamation liability | 6255720 | 6033418 |
| Operating lease - right of use lease liability | 8343588 | 4826785 |
| Deferred revenue (Note 7) | 950000 |  |
| Marathon Simple Agreement for Future Equity ("SAFE") Note | 12000000 |  |
| Debt, net | 8390000 | 8390000 |
| Other liabilities (Notes 7 and 10) | 5055212 | 4179226 |
| Total long-term liabilities | 40994520 | 23429429 |
| TOTAL LIABILITIES | 56355363 | 31540796 |
| COMMITMENTS AND CONTINGENCIES (Notes 10 and 15) |  |  |
| *Stockholders' Equity:* |  |  |
| Preferred stock $0.000666 par value, 50,000,000 shares authorized, no shares outstanding |  |  |
| Common stock, $0.000666 par value, 245,000,000 shares authorized, 32,416,166 and 23,507,577 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively | 164081 | 156590 |
| Additional paid-in capital | 440969432 | 395263560 |
| Accumulated deficit | (352571939) | (335651065) |
| Total equity - Comstock Inc. | 88561574 | 59769085 |
| Non-controlling interest | 3300020 |  |
| Total stockholders' equity | 91861594 | 59769085 |
| TOTAL LIABILITIES & STOCKHOLDERS' EQUITY | $148216957 | $91309881 |

---

*The accompanying notes to the Condensed Consolidated Financial Statements are an integral part of these statements*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6

------

[**Table of Contents**](#toc)

**COMSTOCK INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(UNAUDITED)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Three-Months Ended*** | ***Three-Months Ended*** | ***Six-Months Ended*** | ***Six-Months Ended*** |
|  | ***June 30,*** | ***June 30,*** | ***June 30,*** | ***June 30,*** |
|  | ***2025*** | ***2024*** | ***2025*** | ***2024*** |
| Revenue | $339546 | $434824 | $1125361 | $860775 |
| Cost of goods sold | 814001 |  | 1700797 |  |
| *Operating Expenses:* |  |  |  |  |
| Selling, general and administrative expenses | 4635090 | 2792822 | 7893555 | 6320346 |
| Research and development | 2120645 | 2548467 | 5424563 | 3440480 |
| Depreciation and amortization | 636692 | 656717 | 1012076 | 1312695 |
| Gain on sale of mineral rights | (200000) |  | (200000) |  |
| Total operating expenses | 7192427 | 5998006 | 14130194 | 11073521 |
| Loss from operations | (7666882) | (5563182) | (14705630) | (10212746) |
| *Other Income (Expense):* |  |  |  |  |
| Interest expense | (774062) | (782440) | (1433206) | (1601102) |
| Interest income | 154700 | 65081 | 250809 | 139573 |
| Change in fair value of derivative instruments | 2868176 | (77496) | 1677373 | (833614) |
| Loss on conversion of debt | (2133951) | (1278544) | (3330831) | (1472067) |
| Loss on debt extinguishment |  | (521622) |  | (521622) |
| Gain on extinguishment of liability |  |  | 845000 |  |
| Other income (expense) | (274924) | (494069) | (224389) | (1069014) |
| Total other income (expense), net | (160061) | (3089090) | (2215244) | (5357846) |
| Net loss | (7826943) | (8652272) | (16920874) | (15570592) |
| Net loss attributable to noncontrolling interest |  | (18720) |  | (35628) |
| Net loss attributable to Comstock Inc. | $(7826943) | $(8633552) | $(16920874) | $(15534964) |
| *Earnings per Share - Basic and Diluted:* |  |  |  |  |
| Net loss per share - basic and diluted | $(0.27) | $(0.60) | $(0.63) | $(1.19) |
| Weighted average common shares outstanding, basic and diluted | 29326043 | 14319671 | 26810144 | 13016588 |

---

*The accompanying notes to the Condensed Consolidated Financial Statements are an integral part of these statements*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7

------

[**Table of Contents**](#toc)

**COMSTOCK INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY**

**(UNAUDITED)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  | ***Additional*** |  | ***Treasury*** | ***Non-*** |  |
|  | ***Common Stock*** | ***Common Stock*** | ***Paid in*** | ***Accumulated*** | ***Stock*** | ***Controlling*** |  |
|  | ***Shares*** | ***Amount*** | ***Capital*** | ***Deficit*** | ***Amount*** | ***Interest*** | ***Total*** |
| BALANCE - January 1, 2024 | 11786208 | $78405 | $363889245 | $(282329611) | $(3360867) | $— | $78277172 |
| Issuance of common stock | 410270 | 2732 | 1460978 |  |  |  | 1463710 |
| Common stock issuance costs | *—* |  | (225120) |  |  |  | (225120) |
| Issuance of common stock for stock issuance costs | 25000 | 167 | 84833 |  |  |  | 85000 |
| Issuance of common stock for debt issuance costs | 48914 | 326 | 249674 |  |  |  | 250000 |
| Issuance of common stock for conversion of debt and accrued interest | 227694 | 1516 | 893257 |  |  |  | 894773 |
| Issuance of common stock in lieu of payment of interest | 23961 | 160 | 116443 |  |  |  | 116603 |
| Retirement of treasury shares (260,532 shares) | (260532) | (1735) | (3359132) |  | 3360867 |  |  |
| Employee and director share-based compensation | *—* | 120 | 56064 |  |  |  | 56184 |
| Non-controlling interest vesting of shares in subsidiary | *—* |  | (172600) |  |  | 172600 |  |
| Net loss | *—* |  |  | (6901412) |  | (16908) | (6918320) |
| BALANCE - March 31, 2024 | 12261515 | 81691 | 362993642 | (289231023) |  | 155692 | 74000002 |
| Issuance of common stock | 1554894 | 10356 | 3739644 |  |  |  | 3750000 |
| Issuance of common stock for conversion of debt and accrued interest | *1224456* | 8155 | 3398706 |  |  |  | 3406861 |
| Issuance of common stock in lieu of payment of interest | 37541 | 250 | 123213 |  |  |  | 123463 |
| Issuance of common stock for marketing-related costs | 56101 | 374 | 162319 |  |  |  | 162693 |
| Issuance of common stock for Haywood lease amendment | 150000 | 999 | 508851 |  |  |  | 509850 |
| Issuance of common stock for AST lease amendment | 497500 | 3313 | 1583712 |  |  |  | 1587025 |
| Employee and director share-based compensation | *—* |  | 43149 |  |  |  | 43149 |
| Warrant modification associated with debt amendment | *—* |  | 108230 |  |  |  | 108230 |
| Net loss | *—* |  |  | (8633552) |  | (18720) | (8652272) |
| BALANCE - June 30, 2024 | 15782007 | $105138 | $372661466 | $(297864575) | $— | $136972 | $75039001 |
| BALANCE - January 1, 2025 | 23507577 | $156590 | $395263560 | $(335651065) | $— | $— | $59769085 |
| Common stock issuance costs | *—* |  | (145000) |  |  |  | (145000) |
| Issuance of common stock for debt issuance costs | 110059 | 733 | 531182 |  |  |  | 531915 |
| Issuance of common stock for conversion of debt and accrued interest | 1490624 | 1798 | 3999445 |  |  |  | 4001243 |
| Issuance of common stock in lieu of payment of interest | 35366 | 117 | 142305 |  |  |  | 142422 |
| Adjustment for fractional shares in connection with reverse split | 246 | *—* | *—* | *—* | *—* | *—* | *—* |
| Issuance of common stock for AST lease amendment | 985000 | 656 | 2481544 |  |  |  | 2482200 |
| Issuance of common stock for LINICO acquisition-related payable | 775000 | 516 | 1859484 |  |  |  | 1860000 |
| Net loss | *—* |  |  | (9093931) |  |  | (9093931) |
| BALANCE - March 31, 2025 | 26903872 | 160410 | 404132520 | (344744996) |  |  | 59547934 |
| Issuance of common stock | 625000 | 416 | 1499584 |  |  |  | 1500000 |
| Issuance of common stock for conversion of debt and accrued interest | 2629601 | 1751 | 6736748 |  |  |  | 6738499 |
| Issuance of common stock in lieu of payment of interest | 57693 | 38 | 142066 |  |  |  | 142104 |
| Issuance of common stock for Haywood lease amendment | 200000 | 133 | 699867 |  |  |  | 700000 |
| Issuance of common stock for FPC amendment | 2000000 | 1333 | 5778667 |  |  |  | 5780000 |
| Non-controlling interest of shares in subsidiary for CP Series A investment | *—* |  | 19336362 |  |  | 663638 | 20000000 |
| Non-controlling interest of shares in subsidiary for Founders Group shares | *—* |  | 2643618 |  |  | 2636382 | 5280000 |
| Net loss | *—* |  |  | (7826943) |  |  | (7826943) |
| BALANCE - June 30, 2025 | 32416166 | $164081 | $440969432 | $(352571939) | $— | $3300020 | $91861594 |

---

*The accompanying notes to the Condensed Consolidated Financial Statements are an integral part of these statements*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8

------

[**Table of Contents**](#toc)

**COMSTOCK INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | ***Six-Months Ended*** | ***Six-Months Ended*** |
|  | ***June 30,*** | ***June 30,*** |
|  | ***2025*** | ***2024*** |
| CASH FLOWS FROM OPERATING ACTIVITIES |  |  |
| Net loss | $(16920874) | $(15570592) |
| *Adjustments to reconcile net loss to net cash used in operating activities:* |  |  |
| Depreciation and amortization | 992498 | 1285746 |
| Amortization of finance leases | 25621 | 24043 |
| Amortization on discount associated with finance leases |  | 16445 |
| Amortization of debt discount and other debt-related items | 485853 | 910992 |
| Accretion of reclamation liability | 222302 | 203088 |
| Interest expense paid with common stock | 284526 | 240066 |
| &nbsp;&nbsp;&nbsp; Research and development expense paid with common stock | 1487476 | 1208180 |
| Gain on extinguishment of liability | (845000) |  |
| &nbsp;&nbsp;&nbsp; Loss on conversion of debt | 3330831 | 1472067 |
| Employee and director share based compensation |  | 99333 |
| Change in fair value of derivative instruments | (1677373) | 833614 |
| Share of net (income) loss of equity-method investments | (17438) | 1225185 |
| Gain on write-off of SSOF deposits |  | (400000) |
| Loss on debt extinguishment |  | 521622 |
| Other | 336926 | 302167 |
| *Changes in operating assets and liabilities:* |  |  |
| &nbsp;&nbsp;&nbsp; Accounts receivable | 1502064 | (385676) |
| Prepaid expenses | 65099 | 58321 |
| &nbsp;&nbsp;&nbsp; Deposits | (217500) |  |
| Other assets | (454973) | 222123 |
| Accounts payable | 973634 | 1301050 |
| Accrued expenses, other current liabilities, and deposits | (247712) | 327761 |
| &nbsp;&nbsp;&nbsp; Deferred revenue | 983333 | 23673 |
| Other long-term liabilities | (88478) | 249998 |
| Net cash used in operating activities | (9779185) | (5830794) |
| CASH FLOWS FROM INVESTING ACTIVITIES: |  |  |
| Purchase of mineral rights and properties, plant and equipment | (709572) | (465938) |
| &nbsp;&nbsp;&nbsp; Acquisition of intangible asset | (300000) |  |
| Funding of RenFuel note receivable | (800000) | (1030000) |
| Advances to GenMat |  | (235636) |
| &nbsp;&nbsp;&nbsp; Investment in Hexas SAFE Note | (765334) |  |
| &nbsp;&nbsp;&nbsp; Investment in SSOF | (650000) | (530000) |
| Payments on contractual commitments associated with derivatives | (230000) | (2284364) |
| &nbsp;&nbsp;&nbsp; Payment of reclamation bond deposit | (300000) | (50000) |
| Other | (63788) | (68000) |
| Net cash used in investing activities | (3818694) | (4663938) |

---

*The accompanying notes to the Condensed Consolidated Financial Statements are an integral part of these statements*.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9

------

[**Table of Contents**](#toc)

**COMSTOCK INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)**

**(UNAUDITED)**

---

| | | |
|:---|:---|:---|
| CASH FLOWS FROM FINANCING ACTIVITIES: |  |  |
| Principal payments on financing leases | (23650) | (50131) |
| Principal payments of debt | (100000) | (200000) |
| Issuances of debt | 10000000 | 2000000 |
| Proceeds from the issuance of common stock | 1500000 | 5213710 |
| Common stock issuance costs | (145000) | (140120) |
| Proceeds from the issuance of equity in subsidiary | 20000000 |  |
| Net cash provided by financing activities | 31231350 | 6823459 |
| Net increase (decrease) in cash and cash equivalents | 17633471 | (3671273) |
| Cash and cash equivalents at beginning of period | 954271 | 3785577 |
| Cash and cash equivalents at end of period | $18587742 | $114304 |
| NON-CASH INVESTING AND FINANCING ACTIVITIES: |  |  |
| Acquisition of plant and equipment from Marathon SAFE Note | $12000000 | $— |
| Intangible asset acquired with common stock issued for Flux amendment | $5780000 | $— |
| Intangible asset acquired with derivative liability for Flux amendment | $5087000 | $— |
| Issuance of common stock for Haywood lease amendment | $700000 | $509850 |
| Intangible asset acquired with payable | $4468617 | $— |
| Issuance of common shares for debt conversion and accrued interest | $10739742 | $4301634 |
| Issuance of common stock for AST lease amendment | $2482200 | $378845 |
| Recognition of operating lease liability and right of use asset | $3548557 | $— |
| Issuance of common stock for LINICO acquisition-related payable | $1860000 | $— |
| Intangible asset acquired with issuance of equity in subsidiary | $5280000 | $— |
| Fair value of common stock held by AST transferred to accounts receivable | $722361 | $— |
| Issuance of common stock in lieu of payment of marketing expense | $— | $162693 |
| Fair value of common stock held by GenMat transferred to GenMat Advances | $— | $694970 |
| Issuance of common shares for debt issuance costs | $— | $250000 |
| Investment acquired with payable | $— | $1285961 |
| Issuance of common shares for due diligence and commitment fees | $— | $85000 |

---

*The accompanying notes to the Condensed Consolidated Financial Statements are an integral part of these statements*.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10

------

[**Table of Contents**](#toc)

**COMSTOCK INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**NOTE *1***&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

BUSINESS AND REFERENCES TO THE COMPANY

Unless indicated, the terms *we*, *us*, *our*, *Comstock*, or the *Company* mean Comstock Inc., and its subsidiaries on a consolidated basis.

ORGANIZATION AND NATURE OF OPERATIONS

Comstock innovates and commercializes technologies, systems and supply chains that extract, integrate and convert under-utilized natural and waste resources into clean energy products, including pioneering technologies that produce electrification metals from end-of-life electronics, and investments, like Green Li-ion Pte. LTD ("Green Li-ion"), that produces electrification products from recycled electrification waste and Bioleum Corporation ("Bioleum"), that produces renewable fuels from waste, purpose grown energy crops and other forms of woody biomass.

BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION

The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States ("GAAP") and include the accounts of Comstock Inc. and its wholly and majority owned subsidiaries. Intercompany transactions have been eliminated. The condensed consolidated financial statements do *not* include all disclosures required of annual consolidated financial statements and, accordingly, should be read in conjunction with our consolidated financial statements and notes thereto in our Annual Report on Form *10*-K for the fiscal year ended *December 31, 2024*. Operating results for the *three* and *six*-months ended *June 30, 2025 may not* be indicative of full year *2025* results.

In management's opinion, the accompanying condensed consolidated financial statements contain all adjustments necessary for a fair statement of our financial position as of *June 30, 2025*, and our results of operations and changes in equity for the *three* and *six*-months ended *June 30, 2025* and *2024*, and our cash flows for the *six*-months ended *June 30, 2025* and *2024*.

REVERSE STOCK SPLIT

On *February 24, 2025,* the Company effected a *one*-for-ten (*1:10*) reverse stock split of its issued and outstanding shares of common stock. In connection with the reverse split, all shares of common stock, stock options, per-share and warrant amounts for all periods presented have been adjusted retrospectively to reflect this reverse stock split. This recast ensures comparability across all periods presented and does *not* impact previously reported net income (loss), total assets, or total liabilities but does impact earnings per diluted shares. The reverse stock split did *not* impact the total stockholders' equity, the number of authorized shares of common stock, or the par value per share.

GOVERNMENT GRANT REVENUE

The Company generates grant income from government grants and determined that the grants are *not* within the scope of Accounting Standards Codification ("ASC") *606* as the government entities do *not* meet the definition of a contract with a customer. The Company has concluded that the grants meet the definition of an asset grant under International Accounting Standards ("IAS") *20* and elected to use the deferred income approach to recognized the deferred income over the life of the asset. The Company recognizes funding received from grants as other income, rather than as a reduction of depreciation expense. The Company recognizes other income only after the conditions of grants have been incurred and it is reasonably assured that the conditions will be met. The Company recognizes related deferred revenue in long-term deferred revenue on the condensed consolidated balance sheet which is recognized as grant income over the life of the asset.

LIQUIDITY AND CAPITAL RESOURCES

The condensed consolidated financial statements are prepared on the going concern basis of accounting that assumes the realization of assets and the satisfaction of liabilities in the ordinary course of business. The Company has had recurring net losses from operations and had an accumulated deficit of $352.6 million at *June 30, 2025*. For the *six*-months ended *June 30, 2025*, the Company recognized a net loss of $16,920,874. Cash and cash equivalents increased by $17,633,471 from $954,271 at *December 31, 2024* to $18,587,742 at *June 30, 2025*. The Company intends to fund our operations over the next *twelve* months from revenues from our solar panel recycling business, issuance of equity under our existing shelf registration statement, issuances of debt, sales of non-strategic assets and other investments, and existing cash and cash equivalents. Based on these expected funding sources, management believes we will have sufficient funds to sustain our operations and meet our commitments under our investment agreements during the *12* months following the date of issuance of the condensed consolidated financial statements included herein. While we have been successful in the past in obtaining the necessary capital to support our operations, including registered equity financings from our existing shelf registration statement, non-registered equity placements, non-registered equity issued directly from certain investments, government grants, borrowings, and various other means, there is *no* assurance we will be able to obtain additional equity capital or other financing, if needed.

RECLASSIFICATIONS

Certain prior period amounts have been reclassified to conform to the *2025* financial statement presentation. Reclassifications had *no* effect on net income (loss), cash flows, or stockholders' equity as previously reported.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *11*

------

[**Table of Contents**](#toc)

RECENTLY ISSUED ACCOUNTING STANDARDS

In *December 2023,* the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") *2023*-*09* (*Topic *740*) Improvements to Income Tax Disclosures*. The new guidance is intended to enhance annual income tax disclosures to address investor requests for more information about the tax risks and opportunities present in an entity's operations. The amendments in this standard require disclosure of additional information in specified categories with respect to the reconciliation of the effective tax rate to the statutory rate (the rate reconciliation) for federal, state, and foreign income taxes. They also require greater detail about individual reconciling items in the rate reconciliation to the extent the impact of those items exceeds a specified threshold. In addition to new disclosures associated with the rate reconciliation, the amendments in this update require information pertaining to taxes paid (net of refunds received) to be disaggregated for federal, state, and foreign taxes and further disaggregated for specific jurisdictions to the extent the related amounts exceed a quantitative threshold. The amendments in this update are effective on *January 1, 2025* for annual periods beginning after *December 15, 2024,* and early adoption is permitted. The Company adopted the standard on *January 1, 2025* and does *not* expect the adoption to have a material impact on the consolidated financial statements.

In *November 2024,* the FASB issued ASU *2024*-*03,* Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic *220*-*40*): Disaggregation of Income Statement Expenses, which requires disclosure about the types of costs and expenses included in certain expense captions presented on the income statement. The new disclosure requirements are effective for the Company's annual periods beginning after *December 15, 2026,* and interim periods beginning after *December 15, 2027,* with early adoption permitted, and *may* be applied either prospectively or retrospectively. The Company is currently evaluating the ASU to determine its impact on our consolidated financial statements and disclosures.

Management does *not* believe that any other recently issued, but *not* yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

**NOTE *2***&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**INVESTMENT IN BIOLEUM CORPORATION**

In *May 2025,* Bioleum Corporation ("Bioleum"), a newly formed consolidated subsidiary, issued 2.0 million Series *2* Convertible Preferred Shares to the Bioleum founders ("Founders Group") in exchange for the assignment of developed technologies (see Notes *6* and *11*). The Founders Group consisted of *11* Bioleum founders, all of which were former employees of the Company and *three* of which were former officers of the Company, all *three* of which ceased being officers upon the execution of the Assignment Agreement. On *May 22, 2025,* the Company completed the separation of its renewable fuels segment into Bioleum and on *May 27, 2025,* Bioleum received a *third*-party investment of $20 million in Convertible Preferred Stock - Series A ("CP Series A") issued directly by Bioleum. On *May 21, 2025,* the Company also entered into an Investors' Rights Agreement, Voting Agreement, Right of First Refusal and Co-Sale Agreement, Management Services Agreement with Bioleum (collectively, the "Bioleum Transaction Documents").

*Variable Interest Entity ("VIE") Assessment*

The Company assessed our Bioleum investment under the VIE model in accordance with ASC *810, Consolidation*. The Company holds a variable interest in Bioleum through our restricted convertible preferred stock equity interest and determined that Bioleum is a VIE. The Company considers qualitative and quantitative factors regarding the nature, size and form of our involvement with the VIE including our significant economic interest in Bioleum, a non-controlling *50%* representation on Bioleum's board of directors, and limited participation in the day-to-day management activities. Based on these factors, the Company was determined to be the primary beneficiary of Bioleum. Accordingly, the accounts of Bioleum are included in our condensed consolidated financial statements.

**NOTE *3* INVESTMENTS**

At *June 30, 2025* and *December 31, 2024*, our investments include:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***June 30, 2025*** | ***June 30, 2025*** | ***December 31, 2024*** | ***December 31, 2024*** |
| *Equity Method Investments:* | ***Investment*** | ***Ownership %*** | ***Investment*** | ***Ownership %*** |
| Investment in research and development company | $1127371 | 40.00% | $1109933 | 40.00% |
| Total equity method investments | 1127371 |  | 1109933 |  |
| *Cost Investment:* |  |  |  |  |
| Hexas Biomass Inc. SAFE Note | 765334 |  |  |  |
| *Measurement Alternative Investments:* |  |  |  |  |
| Green Li-ion Pte. Ltd. | 18201065 | 13.34% | 18201065 | 13.34% |
| Sierra Springs Opportunity Fund, Inc. | 20225000 | 17.40% | 19575000 | 17.27% |
| Total measurement alternative investments | 38426065 |  | 37776065 |  |
| Total Investments | $40318770 |  | $38885998 |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *12*

------

[**Table of Contents**](#toc)

Summary financial information for affiliated companies (*20%* to *50%*-owned) accounted for by the equity method for the periods presented, compiled from the equity investee's financial statements and reported on a *one* quarter lag is as follows:

---

| | | |
|:---|:---|:---|
|  | ***Six-Months Ended*** | ***Six-Months Ended*** |
|  | ***June 30, 2025*** | ***June 30, 2024*** |
| Revenues | $701400 | $140300 |
| Gross Profit | $- | $23400 |
| Net income (loss) | $43595 | $(3265035) |
| Net income (loss) attributable to Comstock Inc. | $17438 | $(1225185) |

---

*Investment in Research and Development Company* 

On *March 1, 2024,* the Company entered into Securities Purchase Agreement (the "Developer Securities Purchase Agreement") with an unaffiliated research and development company ("Developer") and recognized an initial investment of $1,290,614. Concurrently and in connection with the entity into the Developer Securities Purchase Agreement, the Company and Developer entered into Development Services Agreement ("DSA") for purposes of conducting certain research and development work (see Note *10*).

At *June 30, 2025*, the future remaining payments, net implied interest, totaled $1,193,140 (see Note *7*). For the *three*-months ended *June 30, 2025* and *2024*, the Company recorded $24,000 and $48,400, respectively in equity loss from affiliates for our investment in the Developer. For the *six*-months ended *June 30, 2025* and *2024*, the Company recorded $17,438 in equity gain from affiliates and $48,400 in equity loss from affiliates for our investment in the Developer. During the *three*-months ended *June 30, 2025* and *2024*, the Company paid $0 and $60,000, respectively, to the Developer in accordance with the funding commitments under the Developer Securities Purchase Agreement. During the *six*-months ended *June 30, 2025* and *2024*, the Company paid $0 and $180,000, respectively, to the Developer in accordance with the funding commitments under the Developer Securities Purchase Agreement.

*Hexas Biomass Inc.* 

On *January 14, 2025,* the Company executed an agreement with Hexas Biomass Inc. ("Hexas"), wherein Hexas agreed to grant the Company an exclusive worldwide license to Hexas' intellectual properties in liquid fuels applications, subject to certain pre-existing agreements and relationships, and to provide certain development services in connection with the Company's site development and innovation activities. The Company also agreed to invest in Hexas through a series of Simple Agreement For Future Equity ("Hexas SAFE"), paid in a series of tranches in *2025.* As of *June 30, 2025*, the Company invested $765,334 in the Hexas SAFE. The Company has elected to account for this investment at cost and classified the Hexas SAFE in Investments on our condensed consolidated balance sheet.

*Investment in Green Li-ion Pte. LTD ("Green Li-ion")*

At *June 30, 2025* and *December 31, 2024,* the Company owned 35,662 Green Li-ion preferred shares and our ownership remained at 13.34%. The Company monitors additional equity issuances and other potential orderly transactions of Green Li-ion to assess whether the equity securities issued are similar investments requiring adjustments of our investments carrying value to fair value. During the *six*-months ended *June 30, 2025* and *2024*, *no* adjustments were made to the carrying value of our investment in Green Li-ion as *no* orderly transactions for investments similar in nature to the Company's were observed during those periods.

*Investment in Sierra Springs Opportunity Fund Inc. ("SSOF")* 

The Company's chief executive officer is an executive of SSOF. The Company concluded that its investment in SSOF is a variable interest entity because the Company has both operational and equity risk related to SSOF, and SSOF currently has insufficient equity at risk. The Company also concluded that it is *not* the primary beneficiary of SSOF because *no one* individual or entity has unilateral control over significant decisions and accordingly, SSOF is *not* consolidated. The Company monitors additional equity issuances and other orderly transactions of SSOF to assess whether the equity securities issued are similar investments requiring adjustments of our investment's carrying value to fair value.

For the *six*-months ended *June 30, 2025*, SSOF issued additional equity of $2,850,000 at $1.80 per share, including $2,200,000 to *third*-party investors for 1,222,222 additional common shares, and $650,000 at $1.80 per share for 361,111 additional common shares to the Company. At *June 30, 2025* and *December 31, 2024,* the Company owns 11,236,111 and 10,875,000, respectively, of SSOF shares and our ownership is at 17.40% and 17.27%, respectively. At *June 30, 2025*, the Company's maximum exposure to loss as a result of its involvement with SSOF is limited to its investment of $20,225,000.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *13*

------

[**Table of Contents**](#toc)

**NOTE *4* NOTES RECEIVABLE** 

Notes receivable at *June 30, 2025* and *December 31, 2024* include:

---

| | | |
|:---|:---|:---|
|  | ***June 30, 2025*** | ***December 31, 2024*** |
| RenFuel K2B AB note receivable | $2250000 | $1450000 |
| Daney Ranch note receivable | 980291 | 980291 |
| Total notes receivable | $3230291 | $2430291 |

---

*RenFuel *K2B* AB (*"*RenFuel*"*)* 

During the *six*-months ended *June 30, 2025*, the Company funded an additional $800,000 associated with the Senior Secured Convertible Note. For the *three*-months ended *June 30, 2025* and *2024*, the Company recognized interest income of $35,851 and $8,078, respectively. For the *six*-months ended *June 30, 2025* and *2024*, the Company recognized interest income of $65,195 and $12,345, respectively. As of *June 30, 2025* and *December 31, 2024,* interest receivable on the note is $123,199 and $58,004, respectively, and is included in prepaid expenses and other current assets on our condensed consolidated balance sheet.

**NOTE *5* PROPERTIES, PLANT AND EQUIPMENT, NET AND MINERAL RIGHTS** 

Properties, plant and equipment at *June 30, 2025* and *December 31, 2024* include the following:

---

| | | |
|:---|:---|:---|
|  | ***June 30, 2025*** | ***December 31, 2024*** |
| Land | $6328338 | $— |
| Real property leased to third parties | 1037049 | 1037049 |
| Property, plant and equipment for mineral processing | 27644746 | 27644745 |
| Other property and equipment | 20400755 | 7691183 |
| Accumulated depreciation | (28148628) | (27767883) |
| Total properties, plant and equipment, net | $27262260 | $8605094 |

---

During the *three*-months ended *June 30, 2025* and *2024*, the Company recognized depreciation expense of $233,065 and $139,060, respectively. During the *six*-months ended *June 30, 2025* and *2024*, the Company recognized depreciation expense of $380,745 and $278,998, respectively. At *June 30, 2025* and *December 31, 2024,* the Company had $655,569 and $433,411, respectively, of properties, plant and equipment that were *not* yet placed in service and have *not* yet begun depreciating.

*Marathon Payment-In Kind Assets* 

On *February 28, 2025,* the Company, entered into a series of definitive agreements with Virent, Inc. ("Virent"), a wholly owned subsidiary of Marathon Petroleum Corporation ("Marathon") (see Notes *10* and *12*). Pursuant to the agreements, the Company received assets comprised of equipment and other materials as payment-in-kind in return for a Simple Agreement For Future Equity ("Marathon SAFE Note") located at Marathon's former renewable fuel demonstration facility in Madison, Wisconsin. The Company accounted for the payment-in-kind as an asset purchase acquisition and recorded payment-in-kind assets plus any direct transaction costs at the estimated relative fair value of the future equity consideration granted through the Marathon SAFE Note. As of *February 28, 2025,* the assets were transferred and the Company recorded at fair value of $12.1 million, including $81,109 of capitalized professional fees, classified in properties, plant and equipment on our condensed consolidated balance sheet.

*Mineral Rights and Properties*

Our mineral rights and properties at *June 30, 2025* and *December 31, 2024* consisted of the following:

---

| | | |
|:---|:---|:---|
|  | ***June 30, 2025*** | ***December 31, 2024*** |
| Comstock Mineral Estate | $10842716 | $10842716 |
| Other mineral properties | 317405 | 317405 |
| Water rights | 820595 | 90000 |
| Total mineral rights and properties | $11980716 | $11250121 |

---

The Comstock Mineral Estate includes all of the Company's resource areas and exploration targets. During the *six*-months ended *June 30, 2025* and *2024*, we did not record any depletion expense, as *none* of the mineral properties are currently in production. Our mineral exploration and mining lease payments are classified as selling, general and administrative expenses in the condensed consolidated statements of operations.

On *December 18, 2024,* the Company executed a membership interest purchase agreement (the "Mackay MIPA") with Mackay Precious Metals Inc. ("Mackay") pursuant to which the Company sold all of its right, title, and interest in its wholly owned subsidiary Comstock Northern Exploration LLC, and the Company's *25%* interest in Pelen Limited Liability Company ("Pelen"), for an aggregate purchase price of $2,750,000. The Northern Targets encompass both the Gold Hill and Occidental Lode claim groups in Storey County, Nevada. Pelen owns certain claims adjacent to and/or relevant to these northern claim groups. The Company was paid $1.0 million in cash in *2024* and was due another $1.75 million in either cash or Mackay's publicly registered common stock that is due and payable. On *June 6, 2025,* the parties executed an amendment (the "First Amendment"), to the Mackay MIPA. Pursuant to the First Amendment, the purchase price was increased to $2,950,000, bringing all final cash amounts due to a total of $1,950,000. As of *June 30, 2025*, the Company received cash payments of $572,945 and recognized *$1,377,055* in accounts receivable on our condensed consolidated balance sheet. As of *August 13, 2025,* the Company received additional cash payments of $949,995 with the final $500,000 cash payment due on or before *August 30, 2025.* For the *three* and *six*-months ended *June 30, 2025*, pursuant to the First Amendment, the Company recognized an additional gain on the sale of mineral rights of $200,000 in our condensed consolidated statement of operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *14*

------

[**Table of Contents**](#toc)

Pursuant to a royalty agreement between the Company and Mackay, dated *December 18, 2024 (*the "Mackay Royalty Agreement") the Company is to receive a 1.5% royalty of Net Smelter Returns (as such term is defined in the Mackay Royalty Agreement). On *December 18, 2024,* the Company and Mackay mutually agreed to terminate the Mineral Exploration and Mining Lease Agreement, dated *June 30, 2023 (*the "Mackay Mining Lease").

For the *three* and *six*-months ended *June 30, 2024*, the Company recorded revenue of $390,626 and $781,251, respectively, related to the Mackay Mining Lease which included the quarterly lease payments of $750,000 and amortization of the lease initiation fee of $31,251. Pursuant to the Mackay MIPA and termination of the Mackay Mining Lease, no additional revenue will be recorded in *2025.*

*Assets Held for Sale* 

In *2024,* the Company committed a plan to sell industrial and commercial land located in Lyon County, Nevada. This balance of $6,328,338 was classified as Assets Held for Sale on the condensed consolidated balance sheet as of *December 31, 2024*. As of *June 30, 2025*, the Company has *not* sold the industrial and commercial land and classified as properties, plant and equipment, net in our condensed consolidated balance sheet and reclassified the land to held and used from held for sale.

In *March 2023,* the Company acquired senior water rights (50-acre feet) associated with *one* of its existing properties and junior water rights (16-acre feet) for a total of $730,595. In *2024,* the Company committed a plan to sell the water rights and reclassified those water rights to Assets Held for Sale on the condensed consolidated balance sheet as of *December 31, 2024*. As of *June 30, 2025*, the Company has *not* sold the senior water rights and classified as mineral rights and properties in our condensed consolidated balance sheet and reclassified the water rights to held and used from held for sale.

The Company's assets held for sale at *June 30, 2025* and *December 31, 2024* include the following:

---

| | | | |
|:---|:---|:---|:---|
| **Assets held for sale** | ***Asset group*** | ***June 30, 2025*** | ***December 31, 2024*** |
| Water rights | *Mineral rights and properties* | $– $| 730595 |
| Land | *Properties, plant and equipment, net* | – | 6328338 |
| *Total assets held for sale* | *Total assets held for sale* | $– $| 7058933 |

---

**NOTE *6* INTANGIBLE ASSETS** 

The Company's intangible assets at *June 30, 2025* and *December 31, 2024* include the following:

---

| | | | |
|:---|:---|:---|:---|
|  | ***Estimated*** |  |  |
|  | ***Economic Life*** |  |  |
| **Description** | ***(in years)*** | ***June 30, 2025*** | ***December 31, 2024*** |
| Developed technologies | 10 | $28980019 | $8064402 |
| License agreements | 10 | 499952 | 499952 |
| Customer agreements | 1 | 122885 | 122885 |
| Distribution agreements | 8 | 19733 | 19733 |
| Accumulated amortization |  | (3459573) | (2847820) |
| Intangible assets, net |  | $26163016 | $5859152 |

---

Accumulated amortization as of *June 30, 2025* and *December 31, 2024* consisted of the following:

---

| | | |
|:---|:---|:---|
|  | ***June 30, 2025*** | ***December 31, 2024*** |
| Developed technologies | $3122803 | $2536716 |
| License agreements | 201897 | 177730 |
| Customer agreements | 122885 | 122885 |
| Distribution agreements | 11988 | 10489 |
| Accumulated amortization | $3459573 | $2847820 |

---

For the *three*-months ended *June 30, 2025* and *2024*, amortization expense related to intangible assets was $393,775 and $503,374, respectively. For the *six*-months ended *June 30, 2025* and *2024*, amortization expense related to intangible assets was $611,753 and $1,006,748, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Amendment to Flux Photon Asset Purchase Agreement*

On *September 7, 2021,* the Company acquired certain intellectual property and related equipment (the "FPC Assets"), pursuant to a certain Asset Purchase Agreement (the "FPC Asset Purchase Agreement") with Flux Photon Corporation ("FPC"). The Company's former chief technology officer and former director is also the owner of 100% of the outstanding common stock of FPC and as such was the indirect beneficiary of all payments made to FPC pursuant to the FPC Asset Purchase Agreement (see Note *15*). The original purchase price included a payable for the FPC Assets of *$18,000,000,* payable only from *20%* of future cash flows defined as the future monthly consolidated sales, less total variable costs, less operating expenses, maintenance, tax payments, and debt service payments of the Company and its subsidiaries until the purchase price was fully paid (the "Earn Out"), against which the Company previously advanced $1,150,000 in cash and applied an *$800,000* discount in consideration for those advance payments, resulting in a remaining balance of *$16,050,000.*

In connection with entering the Bioleum Transaction Documents on *May 21, 2025,* the Company and FPC amended the FPC Asset Purchase Agreement (the "FPC Asset Purchase Agreement Amendment") whereby the Company issued 2,000,000 shares of common stock to FPC, 1,700,000 of such shares will go towards settling $10 million of the Earn Out, with true up provisions for any proceeds received by FPC that are below or in excess of $10 million, and the other 300,000 additional shares of common stock as settlement with certain FPC affiliates. Overall, the Company issued FPC and its affiliates 2,000,000 shares of its common stock with a fair value of $5,780,000 and due to the true up provision recognized a derivative liability of $5,087,000 and intangible asset of $10,867,000 (see Note *12*). During the *three* and *six*-months ended *June 30, 2025,* the Company recorded a gain of $1,530,000 for the change in the fair value of the derivative and as of *June 30, 2025*, the derivative liability was $3,557,000.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *15*

------

[**Table of Contents**](#toc)

After the issuance of the 2,000,000 shares of its common stock to FPC for fulfillment of the Earn Out, Bioleum also retained an additional cash obligation of up to $6,050,000, that will be funded by the Company in exchange for additional CP Series A shares. To the extent that Bioleum raises additional *third*-party funds, 2% of those funds would go directly to satisfying that obligation in lieu of the Company funding the obligation. As of *June 30, 2025*, Bioleum has paid $400,000 directly toward that obligation with the remaining $5,650,000 required to satisfy the FPC cash obligation; with a portion of this remaining obligation to be paid by either the Company, at a rate equal to $120,000 per month for *18* months, and $60,000 per month thereafter, or Bioleum, at a rate of 2% of financing raised by itself and its subsidiaries, until such time as the entire $5,650,000 is paid in full by both the Company and Bioleum, in full settlement of the remaining Earn Out (see Note *7*). The Company has classified $1,440,000 currently as accrued expenses and other liabilities and *$4,210,000* as other long-term liabilities, respectively, at *June 30, 2025*. Bioleum agreed to issue shares of CP Series A shares to the Company in exchange for all of the cash payments made by the Company to Bioleum pursuant to the FPC Asset Purchase Agreement Amendment associated with this obligation. The Company accounted for the cash obligation of $6,050,000 as an acquisition cost of developed technologies and recognized an intangible asset of $4,468,617 and a corresponding short term and long term payable of $952,538 and $3,177,602, respectively, at *June 30, 2025*, for future cash payments for the cash commitment to FPC (see Note *7*). The Company determined the life of the developed technologies intangible assets to be 10 years and recognized amortization expense of $127,797 for the *three* and *six* months ended *June 30, 2025*.

*Bioleum Founder Shares*

Bioleum issued 2.0 million Series *2* Convertible Preferred Shares to the Founders Group in exchange for the assignment of additional developed technologies (see Notes *2* and *11*). The Company accounted for the transaction as an asset acquisition as substantially all of the fair value of the assets acquired were concentrated in a single asset group, which are primarily developed technologies. The Company recognized the assets acquired at the fair value of consideration given and recognized an intangible asset of $5,280,000 and non-controlling equity interest and additional paid in capital of $2,636,382 and $2,643,618, respectively, in our condensed consolidated balance sheet (see Note *11*). The Company determined the life of the developed technologies intangible asset to be 10 years and recognized amortization expense of $44,000 for the *three* and *six* months ended *June 30, 2025*.

Future minimum amortization expense is as follows at *June 30, 2025*:

---

| | |
|:---|:---|
| Remainder of 2025 | $1475738 |
| 2026 | 2951477 |
| 2027 | 2951477 |
| 2028 | 2948731 |
| 2029 | 2948480 |
| Thereafter | 12887113 |
|  | $26163016 |

---

Changes in the intangible assets balances for the *six*-months ended *June 30, 2025* and *2024*, are presented below:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | ***As of December 31, 2024*** | ***Additions*** | ***Impairment*** | ***Amortization*** | ***As of June 30, 2025*** |
| Intangible assets | $8706972 | $20915617 | $– $| *—* | $29622589 |
| Accumulated amortization | (2847820) | *—* | – | (611753) | (3459573) |
| Total intangible assets | $5859152 | $20915617 | $– $| (611753) | $26163016 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | ***As of December 31, 2023*** | ***Additions*** | ***Impairment*** | ***Amortization*** | ***As of June 30, 2024*** |
| Intangible assets | $20242772 | $— | $– $| *—* | $20242772 |
| Accumulated amortization | (4376740) | *—* | – | (1006748) | (5383488) |
| Total intangible assets | $15866032 | $— | $– $| (1006748) | $14859284 |

---

**NOTE *7* ACCRUED EXPENSES AND OTHER LIABILITIES - CURRENT**

Accrued expenses and other liabilities - current at *June 30, 2025* and *December 31, 2024* consisted of the following:

---

| | | |
|:---|:---|:---|
|  | ***June 30, 2025*** | ***December 31, 2024*** |
| Accrued interest expense | $95443 | $353280 |
| Accrued payroll costs | 1168282 | 951247 |
| Accrued incentive compensation | 431250 | 1031250 |
| Accrued vendor liabilities | 205965 | 516804 |
| Payable to research and development company - current | 940529 | 528878 |
| Payable to FPC - current | 952538 |  |
| LINICO acquisition-related payable |  | 1018853 |
| Other accrued expenses | 497842 | 118185 |
| Total accrued expenses | $4291849 | $4518497 |

---

*Payable to FPC* 

Pursuant to the FPC Asset Purchase Agreement Amendment, the Company is required to pay an additional $6,050,000 cash commitment to FPC for the remaining Earn Out due on the FPC Asset Purchase Agreement (see Note *6*). Since the payments are *not* interest bearing, the Company calculated the implied interest of $1,581,383 on the future cash payments using an interest rate of 9.76% which was recognized as a discount on initial intangible asset of $6,050,000 and will be recognized over the payment term. As of *June 30, 2025*, the Company recognized a liability of $4,130,140, net of imputed interest, consisting of a short-term payable of $952,538 and long-term payable of $3,177,602 for future payments due under the FPC Asset Purchase Agreement (as amended). For the *three* and *six*-months ended *June 30, 2025*, the Company recognized interest expense of $61,522 which represents the amortization of the discount that was recognized on the date of the agreement since the payable associated with the commitment is non-interest bearing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *16*

------

[**Table of Contents**](#toc)

*Payable to Research and Development Company* 

As of *June 30, 2025*, the short-term payable to a research and development company ("Developer") of $940,529 and long-term payable of $252,611 consists of payments due under the Securities Purchase Agreement dated *March 1, 2024,* between the Company and Developer (see Note *3*). During the *three*-months ended *June 30, 2025* and *2024*, the Company paid $0 and $60,000, respectively, to the Developer in accordance with the funding commitments under the Developer Securities Purchase Agreement. During the *six*-months ended *June 30, 2025* and *2024*, the Company paid $0 and $180,000, respectively, to the Developer in accordance with the funding commitments under the Developer Securities Purchase Agreement. For the *three*-months ended *June 30, 2025* and *2024*, the Company recognized interest expense of $30,183 and $33,104, respectively, which represents the amortization of the discount that was recognized on the date of the agreement since the payable associated with the funding commitment is non-interest bearing. For the *six*-months ended *June 30, 2025* and *2024*, the Company recognized interest expense of $60,035 and $44,467, respectively.

*Accrued Incentive Compensation*

On *July 1, 2022,* the Board of Directors of the Company approved a performance objective based, cash incentive compensation plan for executives of the Company, with the potential to earn a performance bonus of up to 100% of base salary.

Changes in the accrued incentive compensation balance at *June 30, 2025* are presented below:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***As of December 31, 2024*** | ***Paid in 2025*** | ***Award Cancelled*** | ***As of June 30, 2025*** |
| Executive incentive accrual - 2024 | $1031250 | $– $| 600000 | $431250 |

---

In *2024,* the Company estimated the *2024* incentive compensation accrual to be $1,031,250. As of *March 31, 2025,* the Company estimated that the Compensation Committee of the Board of Directors would approve a final, lower *2024* incentive award of $431,250 based on the final assessment of progress made on the original *three* year objectives of the *2024* incentive plan that are expected to be paid in the *second* half of *2025.* For the *three* and *six*-months ended *June 30, 2025*, the Company accordingly reduced the estimated *2024* incentive accrual by $0 and $600,000, respectively.

Changes in the accrued incentive compensation balance at *June 30, 2024* are presented below:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***As of December 31, 2023*** | ***Expensed*** | ***Award Cancelled*** | ***As of June 30, 2024*** |
| Executive incentive accrual - 2023 | $1332169 | $- | $507169 | $825000 |
| Executive incentive accrual - 2024 |  | 412500 |  | 412500 |
| Total executive incentive accrual | $1332169 | $412500 | $507169 | $1237500 |

---

For the *three* and *six*-months ended *June 30, 2024*, the Company expensed $103,125 and $412,500, respectively, for the *2024* accrued incentive compensation in the condensed consolidated financial statements. In *2024,* the Company's Compensation Committee of the Board of Directors determined that the estimated $1,332,169 for the *2023* incentive compensation would *not* qualify for payment based on an updated intermediate assessment of the progress made toward the objectives of the *three* year incentive plan. The Company accordingly reduced the estimated *2023* accrued incentive compensation by $507,169 and $825,000, respectively, in the *second* and *third* quarters of *2024.*

*LINICO Acquisition-Related Payable* 

As of *December 31, 2024,* the total LINICO acquisition-related payable due to the former chief executive officer of LINICO ("Former LINICO CEO") was $3,218,853 which consisted of a short-term payable of $1,018,853 and long-term payable of $2,200,000. In *January 2025,* the Company made an additional cash payment of $25,000 to reduce the payable to $3,193,853.

On *February 28, 2025,* the Company entered into an amendment to make anticipated final payments consisting of $148,853 in cash and issued 775,000 common shares of the Company with a fair value of $1,860,000 in an effort to settle all amounts payable to the Former LINICO CEO in full. The Company paid $148,853 against the LINICO acquisition-related payable as of *June 30, 2025*. The settlement was designed to fully satisfy the existing obligation of $3.2 million and resulted in a gain of $845,000 recognized in the *first* quarter of *2025* as a gain on extinguishment of liability in our condensed consolidated statement of operations. The Company agreed to make up any shortfall if the proceeds from the sale of the shares of common stock are less than $2.2 million, and the Former LINICO CEO agreed to refund any excess proceeds (see Note *12*). The Company further agreed to register the Company's common stock for resale by Former LINICO CEO under the Securities Act of *1933,* as amended, which became effective on *March 28, 2025.* The contractual stock consideration was recognized as a derivative on the condensed consolidated balance sheets (see Note *12*). 

As of *June 30, 2025,* all common shares of the Company were sold by the Former LINICO CEO and all obligations were settled in full. In *June, 2025,* the Company received cash of $60,170 representing cash from the sale of the common shares in excess of amounts owed.

*Oklahoma Grant* 

On *December 11, 2024,* the Company was granted an award of $3,000,000 (the "OKL Award"), pursuant to that Contract between the Oklahoma Department of Commerce and the Company for a contractual award from the Oklahoma Quick Action Closing Fund (the "Contract"). The OKL Award funds in three tranches of $1,000,000 each within *45* days Comstock Fuels Corporation ("Comstock Fuels"), a wholly owned subsidiary of the Company, meeting these *three* conditions:

• publicly announcing the relocation of the Comstock Fuels headquarters to Oklahoma, which was completed in the *first* quarter of *2025;*

• identifying an Oklahoma site for the construction of a next-generation renewable fuel refinery and secures that site; and

• invests at least $5,000,000 towards engineering, machinery, and/or materials associated with that Oklahoma site/facility.

The OKL Award must be used for purposes of economic development and related infrastructure development. The Award requires certain ongoing conditions to be met, including without limitation, creation of 45 jobs, with an average salary of $80,000 per person, $160 million of total investments, maintenance of headquarters by *March 31, 2026,* with at least *ten* jobs for a period of at least *ten* consecutive quarters *no* later than *December 31, 2030,* and operation of a commercial demonstration biorefinery *no* later than *December 31, 2031,* otherwise the granted monies received would have to be repaid. In the *first* quarter of *2025,* the Company met the *first* condition of the OKL Award and received $1.0 million from the Oklahoma Department of Commerce. For the *three* and *six*-months ended *June 30, 2025*, the Company recognized grant income of $8,333 and $16,666, respectively, in other income (expense) in the condensed consolidated statement of operations and recognized deferred revenue of $33,334 in accrued expenses and other liabilities and $950,000 in long-term deferred revenue on the condensed consolidated balance sheet.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *17*

------

[**Table of Contents**](#toc)

**NOTE *8* LEASES**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The Company has lease balances recognized on the condensed consolidated balance sheets as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Lease Assets and Liabilities** | ***Classification*** | ***June 30, 2025*** | ***December 31, 2024*** |
| Finance lease right-of-use asset | *Finance lease - right of use asset, net* | $3062541 | $3088188 |
| Operating lease right-of-use asset | *Operating lease - right of use asset, net* | 7982457 | 4650862 |
| Total right of use assets |  | $11044998 | $7739050 |
| Operating lease liability - current | *Accrued expenses and other liabilities* | $148692 | $44758 |
| Operating lease liability - long-term | *Operating lease - right of use lease liability* | 8343588 | 4826785 |
| Finance lease liability, current portion | *Finance lease - right of use lease liability* |  | 490075 |
| Total lease liabilities |  | $8492280 | $5361618 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Company has the following lease costs recognized in the condensed consolidated statements of operations as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Three-Months Ended*** | ***Three-Months Ended*** | ***Six-Months Ended*** | ***Six-Months Ended*** |
|  | ***June 30, 2025*** | ***June 30, 2024*** | ***June 30, 2025*** | ***June 30, 2024*** |
| Finance lease cost: |  |  |  |  |
| Amortization of right-of-use assets | $12810 | $12810 | $25621 | $24043 |
| Interest on lease liabilities |  |  |  | 16445 |
| Operating lease cost: | 406418 | 17433 | 704166 | 34867 |
| Total lease cost | $419228 | $30243 | $729787 | $75355 |
| Other information: |  |  |  |  |
| Operating cash flows from operating leases | $253791 | $16590 | $415023 | $33180 |

---

The Company has the following weighted average remaining lease terms and discount rates for our finance and operating leases:

---

| | | |
|:---|:---|:---|
|  | ***June 30, 2025*** | ***June 30, 2024*** |
| Weighted-average remaining lease term - finance leases (years) | *—* | 0.83 |
| Weighted-average remaining lease term - operating leases (years) | 10.10 | 4.37 |
| Weighted-average discount rate - finance leases | —% | —% |
| Weighted-average discount rate - operating leases | 13.5% | 13.2% |

---

*Finance Lease*

*AST Asset Purchase Agreement* 

On *March 20, 2025,* the Company and American Science and Technology Corporation ("AST") amended the License Agreement Amendments (the "Second License Agreement Amendments") to supplement the Purchase Consideration and License Consideration such that additional consideration was delivered in the form of the Company's common stock. The Second License Agreement Amendments requires the Company to:

• Cease monthly $35,000 rental payments;

• Issue 985,000 shares of its common stock to AST pursuant to the Second License Agreement Amendments;

• Accrue interest payments on the remaining principal at a rate of 12% per annum, pursuant to the terms of the Second License Agreement Amendments (the "True Up Payment");

• Pay AST, on or before *November 15, 2025,* an amount equal to $2,935,386 plus accrued interest minus the net cash proceeds AST received from the sale of the Company's shares of common stock; and

• Return any excess shares and/or cash from AST to the Company, if on *November 15, 2025,* the value of the unsold shares plus the net cash proceeds received by AST from the sale of Company shares exceeds the remaining closing costs.

On *March 20, 2025,* pursuant to the Second License Agreement Amendments, the Company issued 985,000 shares of its common stock to AST with a fair value of $2,482,200 determined by the closing price per share of our common stock. The fair value of $2,482,200 for the 985,000 issued shares of common stock was allocated as a reduction to the remaining lease liability of $466,423, recognition of research and development expense of $1,487,476 and recognition of a derivative asset of $480,540. This contractual stock consideration was recognized as a derivative (see Note *12*). 

As of *June 30, 2025*, AST holds 154,656 shares of the Company's stock which includes the 985,000 shares issued under the Second license Agreement Amendments, 497,500 shares issued in *2024* under a separate amendment, reduced by 1,327,844 shares sold by AST through *June 30, 2025*. As of *June 30, 2025*, all obligations to AST were settled in full and the Company is due $722,361 comprised of the excess net proceeds received by AST from the sale of the Company's shares of $284,684 and an additional $437,677 which represents the fair value of the Company's common stock held by AST which will be reimbursed back to the Company. The AST reimbursement of excess proceeds from the sale of the Company's stock of $722,361 is recognized in accounts receivable on the condensed consolidated financial statements.

For the *three*-months ended *June 30, 2025* and *2024*, the Company recognized interest expense of $49,083 and $70,192, respectively, in connection with the 12% stated interest rate pursuant to the terms of the True Up Payment. For the *six*-months ended *June 30, 2025* and *2024*, the Company recognized interest expense of $134,592 and $70,192, respectively, in connection with the 12% stated interest rate pursuant to the terms of the True Up Payment. As of *June 30, 2025*, all obligations, including the True Up Payment, to AST were settled in full.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *18*

------

[**Table of Contents**](#toc)

All of the assets purchased under the initial lease agreement are being used for research and development activities. The machinery and equipment acquired was built for a specific purpose and is being used in testing for development of the technology required to process woody biomass into intermediate materials that can be converted into pulp, paper and fuels. These assets have *no* alternative future use. The facility is an industrial property located in Wausau, Wisconsin with alternative uses. Since its inception, payments under this contract were allocated to the separate lease and non-lease components of the contract based on their standalone estimated fair values. During the *three*-months ended *June 30, 2025* and *2024*, the Company recognized $0 and $1,288,115 respectively, of research and development expense associated with payments under this agreement. During the *six*-months ended *June 30, 2025* and *2024*, the Company recognized $1,562,901 and $1,368,050, respectively, of research and development expense associated with payments under this agreement. The expense for the *six*-months ended *June 30, 2025*, includes $1,487,476 from the stock consideration from the Second License Agreement Amendments discussed above.

*Haywood Quarry Acquisition and Lease Agreement* 

On *April 2, 2024,* the Company and Decommissioning Services amended the Haywood Purchase Agreement to extend the latest date of the closing to *June 30, 2025,* and to increase the purchase price by $100,000 to $2.2 million. Pursuant to the amendment, the Company will pay $75,000 per month to Decommissioning Services, with $15,000 of each payment applied to rent expense and $60,000 of each payment applied to the $2.2 million purchase price, until the sum of such applied cash amounts plus previous cash payments plus the net proceeds from the sale of the shares of Company common stock equals $2.2 million. On *April 11, 2024,* pursuant to the amendment, the Company issued an additional 150,000 shares of the Company's common stock to Decommissioning Services with a fair value of $509,850. The payment was applied against the make-whole derivative liability associated with the common stock. The increase in purchase price from $2.1 million to $2.2 million increased the right-of-use finance lease asset and the make-whole derivative liability by $100,000 (see Note *12*)*.* 

On *June 9, 2025,* the parties amended the Purchase Agreement (the "Third Amendment") to extend the latest date of the closing to *December 31, 2025,* and issue an additional 200,000 common shares of the Company to Decommissioning Services. Pursuant to the Third Amendment, Comstock Exploration will not be required to make cash payments following any month in which the sale of any common shares of the Company held by Decommissioning Services results in proceeds greater than $60,000. Pursuant to the Third Amendment, the Company issued an additional 200,000 shares of the Company's common stock to Decommissioning Services with a fair value of $700,000. The payment was applied against the make-whole derivative liability associated with the common stock.

For the *three*-months ended *June 30, 2025* and *2024*, the Company paid Decommissioning Services $110,000 and $120,000, respectively, which resulted in a decrease in contractual stock consideration. For the *six*-months ended *June 30, 2025* and *2024*, the Company paid Decommissioning Services $230,000 and $120,000, respectively, which resulted in a decrease in contractual stock consideration (see Note *12*). As of *June 30, 2025*, Decommissioning Services sold 290,000 shares of the Company's stock for net proceeds of $971,268 and holds 210,000 shares of the Company's stock.

*Operating Leases*

On *August 15, 2023,* the Company, as lessee, signed a Real Estate and Building Lease Agreement (the "SCP Building Lease") with Sierra Clean Processing LLC ("SCP") to lease real property and improvements located in Silver Springs, Nevada. For the *three*-months ended *June 30, 2025* and *2024*, the fixed operating lease expense was $14,908. For the *six*-months ended *June 30, 2025* and *2024*, the fixed operating lease expense was $29,816.

On *July 1, 2024,* the Company, as lessee, signed a Real Estate and Building Lease Agreement (the "SCP Real Estate and Building Lease") with SCP to lease real property and improvements located in Silver Springs, Nevada. For the *three* and *six*-months ended *June 30, 2025*, the fixed operating lease expense were $217,875 and $435,750, respectively.

The Company's chief executive officer is an executive and director of SCP.

On *January 22, 2025,* the Company, as lessee, signed a Building Lease Agreement (the "Oklahoma Office Lease") with Gaillardia Parkway LLC to lease real property and improvements located in Oklahoma City, OK. The Oklahoma Office Lease is under a *three*-year term which commenced on *February 1, 2025,* with *no* extension provision. Under the lease, rental expense is $5,244 per month for the *first twelve* rent payments, $5,403 per month for the next *twelve* months and $5,566 per month for the last *twelve* months of the lease term. At lease inception, the Oklahoma Office Lease was classified as an operating lease with a lease term of *three* years. At *February 1, 2025,* the Company recorded a right-of-use asset and lease liability of $160,102, at a discount rate of 12.95%. For the *three* and *six*-months ended *June 30, 2025*, the fixed operating lease expense were $16,213 and $27,022, respectively.

On *February 27, 2025,* the Company, as lessee, signed a Commercial Lease Agreement (the "Madison Commercial Lease") with McAllen Properties Dane LLC to lease commercial property and improvements located in Madison, WI (see Note *10*). The Madison Commercial Lease is under an initial *seven*-year term which commenced on *March 1, 2025* with an optional renewal term of *five* years. The Company expects to exercise the optional *five*-year renewal term. Under the lease, rental expense starts at $43,657 per month and escalates at fixed rates annually through the *twelve*-year term. At lease inception, the Madison Commercial Lease was classified as an operating lease with a lease term of *twelve* years. At *February 27, 2025,* the Company recorded a right-of-use asset and lease liability of $3,388,455, at a discount rate of 14.24%, commensurate to a twelve-year lease term, inclusive of the five-year renewal term. For the *three* and *six*-months ended *June 30, 2025*, the fixed operating lease expense were $154,896 and $206,529, respectively.

For the *three*-months ended *June 30, 2025* and *2024*, short-term operating lease expense was $63,402 and $24,800, respectively. For the *six*-months ended *June 30, 2025* and *2024*, short-term operating lease expense was $92,996 and $45,500, respectively.

Minimum lease payments to be paid by the Company by fiscal year for the Company's operating and finance leases are as follows:

---

| | |
|:---|:---|
|  | ***Operating Leases*** |
| For the remainder of 2025 | $508356 |
| 2026 | 1597836 |
| 2027 | 1653005 |
| 2028 | 1581625 |
| 2029 | 1546778 |
| Thereafter | 9151909 |
| Total lease payments | 16039509 |
| Less: imputed interest | (7547229) |
| Present value of lease liabilities | $8492280 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *19*

------

[**Table of Contents**](#toc)

*Operating Lease Income*

For the *three*-months ended *June 30, 2025* and *2024*, revenues from operating leases on our land and building leased to others totaled $36,550, and $36,600, respectively. For the *six*-months ended *June 30, 2025* and *2024*, revenues from operating leases on our land and building leased to others totaled $73,600 and $71,925, respectively.

Minimum lease payments for operating leases to be received from others are as follows:

---

| | |
|:---|:---|
| For the remainder of 2025 | $48000 |
| 2026 | 96000 |
| 2027 | 96000 |
| 2028 | 96000 |
| 2029 | 96000 |
| Thereafter | 96000 |
| Total Minimum Lease Income | $528000 |

---

**NOTE *9*** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **DEBT OBLIGATIONS** 

Debt at *June 30, 2025* and *December 31, 2024* consisted of the following:

---

| | | |
|:---|:---|:---|
|  | ***June 30, 2025*** | ***December 31, 2024*** |
| GHF Secured Promissory Note - 12% interest, due April 15, 2026 | $4290000 | $4290000 |
| Alvin Fund LLC 2022 Note - 16% interest, due April 15, 2026 | 2000000 | 2000000 |
| Alvin Fund LLC 2023 Note - 12% interest, due April 15, 2026 | 2100000 | 2100000 |
| 2025 Kips Bay Unsecured Convertible Promissory Note - 6% interest, due April 10, 2026 | 2190525 |  |
| AQMS Note Payable - 9.76% implied interest, due March 31, 2025 |  | 100000 |
| Total debt | 10580525 | 8490000 |
| Less: debt discounts and issuance costs | (407461) | (2407) |
| Total debt, net of discounts | 10173064 | 8487593 |
| Less: current maturities | (1783064) | (97593) |
| Long-term debt, net of discounts and issuance costs | $8390000 | $8390000 |

---

*GHF, Inc. Unsecured Promissory Note*

During the *three*-months ended *June 30, 2025* and *2024*, the Company recognized interest expense of $128,347 and $133,884, respectively, including OID amortization of $0 and $21,755 respectively, in connection with this note. During the *six*-months ended *June 30, 2025* and *2024*, the Company recognized interest expense of $255,284 and $292,331, respectively, including OID amortization of $0 and $116,028 respectively, in connection with this note. On *April 22, 2024,* the Company and GHF amended the note (the "Amended GHF *2021* Note") to extend the maturity from *December 15, 2024* to *April 15, 2026* and increase the interest rate from 6% to 12% per annum. The Company determined that the Amended GHF *2021* Note resulted in a debt modification and recorded in the *second* quarter of *2024* a loss on debt extinguishment of $331,891 in our condensed consolidated statement of operations. The principal due on the GHF *2021* Note of $4,290,000 has been reassigned to Georges Trust (See Note *16*).

*Alvin Fund *2022* Note*

During the *three*-months ended *June 30, 2025* and *2024*, the Company recognized interest expense of $79,781 and $79,781, respectively in connection with the Alvin Fund *2022* Note. During the *six*-months ended *June 30, 2025* and *2024*, the Company recognized interest expense of $158,685 and $159,562, respectively in connection with the Alvin Fund *2022* Note. As of *June 30, 2025* and *2024*, the Company issued an aggregate of 53,281 and 42,437 shares of unregistered restricted shares of common stock, respectively, with a fair value of $159,562 and $160,439, respectively, to Alvin Fund in lieu of cash payments for interest under the Alvin Fund *2022* Note. On *April 22, 2024,* the Company and Alvin Fund LLC amended the Alvin Fund *2022* Note to extend the maturity from *January 31, 2026* to *April 15, 2026 (*See Note *16*).

*Alvin Fund *2023* Note*

During the *three*-months ended *June 30, 2025* and *2024*, the Company recognized interest expense of $62,827 and $69,100, respectively, which includes OID amortization of $0 and $11,796, respectively, in connection with the Alvin Fund *2023* Note. During the *six*-months ended *June 30, 2025* and *2024*, the Company recognized interest expense of $124,965 and $162,102, respectively, which includes OID amortization of $0 and $62,913, respectively, in connection with the Alvin Fund *2023* Note. As of *June 30, 2025* and *2024*, the Company issued an aggregate of 39,778 and 19,065 shares of unregistered restricted shares of common stock, respectively, with a fair value of $124,964 and $79,627, respectively, to Alvin Fund in lieu of cash payments for interest under the Alvin Fund *2023* Note. On *April 22, 2024,* the Company and Alvin Fund LLC amended the Alvin Fund *2023* Note to extend the maturity from *February 12, 2025* to *April 15, 2026* and increase the interest rate from 8% to 12% per annum. The Company determined that the Amended Alvin Fund *2023* Note resulted in a debt modification and recorded in the *second* quarter of *2024* a loss on debt extinguishment of $189,731 in our condensed consolidated statement of operations (See Note *16*).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *20*

------

[**Table of Contents**](#toc)

*Kips Bay Select LP Unsecured *2025* Convertible Note*

On *January 10, 2025,* the Company entered into a securities purchase agreement (*"2025* Kips Bay Agreement") for an unsecured convertible promissory note (the *"2025* Kips Bay Note") with Kips Bay with a principal amount of $10,638,298, of which $5,000,000 was funded in cash on *January 13, 2025* with an original issue discount of $319,149. On *March 11, 2025,* the Company received additional funding of $5,000,000, which resulted in a principal amount for such *second* tranche of $5,319,149 (that is, an additional $5,000,000 in cash plus an additional $319,149 of original issue discount). The full principal is due on *April 10, 2026.* Interest is payable monthly at a rate of 6% per annum. In accordance with the agreement, in *2025,* the Company issued 110,059 shares of its common stock (44,024 restricted and 66,035 registered) with a fair value of $531,915 as debt issuance costs. The amount was recognized as additional discount on the note. The *2025* Kips Bay Note contains conversion terms that are based on percentages of trading price and volumes. The terms require the conversion option to be bifurcated as a derivative. The initial derivative recorded totaled $1,920,000 and resulted in additional discount on the note (see Note *12*).

During the *three* and *six*-months ended *June 30, 2025*, the Company recognized interest expense of $369,714 and $644,598, respectively, which includes OID amortization of $271,555 and $483,446, in connection with the *2025* Kips Bay Note.

During *2025,* pursuant to the *2025* Kips Bay Note, the Company issued 4,120,225 shares of the Company's common stock to Kips Bay with a fair value of $10,739,742 at an average conversion price of $2.61 (See Note *16*).

The loss on debt conversion recognized during the *six*-months ended *June 30, 2025* was calculated as follows:

---

| | |
|:---|:---|
| Principal converted | $8447773 |
| Debt discount associated with principal converted | (2199306) |
| Accrued interest payable converted | 134125 |
| Derivative liability converted | 1026319 |
| Total | 7408911 |
| Fair value of stock issued (4,120,225 shares) | 10739742 |
| Loss on conversion of debt | $(3330831) |

---

*AQMS Note*

During the *three*-months ended *June 30, 2025* and *2024*, the Company recognized interest expense of $0 and $9,737, respectively, in connection with the AQMS note payable. During the *six*-months ended *June 30, 2025* and *2024*, the Company recognized interest expense of $2,407 and $23,124, respectively, in connection with the AQMS note payable. As of *March 26, 2025,* the AQMS note payable was paid off in full.

**NOTE *10* COMMITMENTS AND CONTINGENCIES** 

COMSTOCK MINERAL ESTATE LEASE PAYMENTS

We lease certain mineral rights and properties under leases expiring at various dates through *2027.* Future minimum annual lease payments, including royalty and rental payments, under these existing lease agreements are as follows at *June 30, 2025*:

---

| | |
|:---|:---|
| **Year** | ***Leases*** |
| Remainder of 2025 | $— |
| 2026 | 12000 |
| 2027 | 12000 |
| Total minimum annual lease payments | $24000 |

---

NORTHERN COMSTOCK OPERATING AGREEMENT

The Company has an Operating Agreement with Northern Comstock LLC, as amended *August 27, 2015.* The Operating Agreement requires that the Company make monthly cash contributions of $30,000 for *eleven* months each calendar year to Northern Comstock LLC and an annual contribution in the amount of $482,500 payable in stock or cash. During the *three*-months ended *June 30, 2025* and *2024*, the Company recognized expense associated with the Operating Agreement of $222,236 in selling, general, and administrative expense on the condensed consolidated income statements. During the *six*-months ended *June 30, 2025* and *2024*, the Company recognized expense associated with the Operating Agreement of $444,472 in selling, general, and administrative expense on the condensed consolidated income statements. At *June 30, 2025* and *December 31, 2024*, approximately $570,000 and $390,000, respectively, in scheduled cash contributions were included in accounts payable on the condensed consolidated balance sheets. The Company anticipates making these contribution payments through the remainder of the required term (*September 2026)* to fully satisfy the obligation.

RENFUEL LICENSE PAYMENTS

On *October 11, 2023,* as amended on *December 22, 2023,* the Company and RenFuel signed an Exclusive License Agreement, pursuant to which RenFuel granted Comstock Fuels an exclusive license to use RenFuel's patented catalytic esterification and related technologies in North America, Central America, and South America in exchange for ongoing royalty fees based on the production and sales of qualified products. On *February 19, 2025,* Comstock Fuels and RenFuel executed another amendment to the Exclusive License Agreement to expand the territory from North, Central, South America, Australia, New Zealand, and Vietnam to worldwide except for Europe.

The Company is required to spend a minimum of $250,000 per quarter on commercially reasonable research, development and commercialization activities. As of *June 30, 2025*, this commitment remains satisfied (see Note *4*).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *21*

------

[**Table of Contents**](#toc)

INVESTMENT IN LICENSED TECHNOLOGY

*Developer (see Note *3*)*

On *March 1, 2024,* the Company and Developer entered into the DSA to advance technologies owned by the Company's subsidiary that incorporate applications of intellectual properties owned by the Developer ("Developer IP") (See Note *3*). For the *three*-months ended *June 30, 2025* and *2024*, the Company recorded $350,700 and $350,700, respectively, as research and development expense in the condensed consolidated statements of operations. For the *six*-months ended *June 30, 2025* and *2024*, the Company recorded $701,400 and $467,600, respectively, as research and development expense in the condensed consolidated statements of operations. On *March 1, 2024,* Developer granted the Company an exclusive license to use Developer IP to produce fuel ("Fuels License") and treat water ("Water License" and, together with the Fuels License, the "Comstock License Agreements") in exchange for royalty fees based on the production and sales of qualified products. The Comstock License Agreements also require the Company to pay minimum royalty fees equal to $20,000 on the earlier to occur of *240* days after receiving a patent for the Developer IP, and, commenced on *February 15, 2025,* and for each year thereafter, (i) $10,000 in year *1* and *2,* (ii) $25,000 in year *3* and *4,* and (iii) $75,000 in year *5* and thereafter. The Company also agreed to pay for certain outstanding and future patent costs, as well as a new patent filing fees for each new patent application added to the Licensed Patent Rights deriving from Developer individually ($10,000) or together with the Company ($5,000). The scope of the Water License is exclusive unless Comstock elects *not* to invest a minimum of $100,000 per calendar quarter after completion of Phase *1.* As of *June 30, 2025*, in accordance with the funding commitments under the Comstock License Agreements, the Company paid $205,204 of patent fee expense. As of *June 30, 2025*, payables to the Developer included in accounts payable on the condensed consolidated balance sheet was *$1,519,700.*

*NREL* 

On *October 1, 2024,* the Company entered into an agreement with a managing and operating contractor of the U.S. Department of Energy's ("DOE") National Renewable Energy Laboratory ("NREL"). The agreement provides that the Company fund the research which includes the use of its pilot facility, equipment and laboratory in Wisconsin. The ongoing funding commitment is $1.5 million, $1.7 million, and $1.5 million, during *2025, 2026,* and *2027,* respectively. For the *three* and *six*-months ended *June 30, 2025*, $404,232 and $808,464, respectively, has been funded under the agreement and recognized as research and development expense.

On *October 1, 2024,* the Company entered into an exclusive licensing agreement with the same party whereby the Company obtained exclusive license in existing or future patent rights associated with the research. The licensing agreement required the Company to pay fees of $100,000 that were recognized as research and development expense during the year ended *December 31, 2024.* Under this licensing agreement, the Company will pay a royalty fee equal to 3% of net sales. The agreement includes minimum annual royalty payments that are *not* applied against future years' royalty payments. For the *six*-months ended *June 30, 2025*, the Company paid $65,000 in annual royalty fees recognized as research and development expense in our condensed consolidated statement of operations. Annual royalty payments are as follows:

---

| | |
|:---|:---|
|  | **Minimum Annual Royalty** |
| For the remainder of 2025 | $- |
| 2026 | $90000 |
| 2027 | $95000 |
| 2028 | $125000 |
| 2029 | $135000 |
| Thereafter | $150000 |

---

The Company has sublicensing rights and will pay a royalty fee equal to 15% of any such sublicensing revenue to NREL. The royalty fee and the sublicensing fee will be reduced to 2% and 10%, respectively, upon achievement of certain thresholds.

*SACL Pte. Ltd.* 

On *January 30, 2025,* the Company executed a master license agreement ("Master License Agreement") with SACL Pte. Ltd. ("SACL"), a Singapore-based project development and management company that intends to develop renewable energy projects in Australia, New Zealand, Vietnam, Cambodia, and Malaysia (the "Territory"). Under the terms of the Master License Agreement, the Company granted SACL (*1*) a master non-exclusive license to Comstock Fuels' intellectual property ("Licensed IP") for the sole purpose of developing, financing, building, and managing of renewable fuels production facilities based on the Licensed IP in the Territory (each, a "Licensed Facility), and (*2*) limited exclusive rights to market projects based on the Licensed IP in the Territory, subject to SCAL's satisfaction of commercialization milestones relating to development of its projects; including, without limitation, completion of engineering and financing for SACL's *first* Licensed Facility in *2025,* followed by commissioning and commencement of production in *2027.*

*Gresham's Eastern (Pvt) Ltd.* 

On *February 12, 2025,* the Company also executed a Master License Agreement with Gresham's Eastern (Pvt) Ltd ("Gresham's"), a Pakistan-based, sustainable energy engineering, equipment and construction company that intends to develop renewable energy projects in Pakistan. Under the terms of Gresham's Master License Agreement, the Company granted Gresham's (*1*) a master non-exclusive license to Comstock Fuels' intellectual property ("Licensed IP") for the sole purpose of developing, financing, building, and managing of renewable fuels production facilities based on the Licensed IP in the Territory (each, a "Licensed Facility), and (*2*) limited exclusive rights to market projects based on the Licensed IP in the Territory, subject to Gresham's satisfaction of commercialization milestones relating to development of its current and future projects; including, without limitation, completion of engineering and financing for Gresham's *first* Licensed Facility in *2025,* followed by commissioning and commencement of production in *2027.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *22*

------

[**Table of Contents**](#toc)

*Marathon Petroleum Corporation*

<u>Investment Agreements</u>

On *February 28, 2025,* Comstock Fuels entered into a series of definitive agreements with Virent, involving the purchase of $14.0 million in Comstock Fuels equity as part of Comstock Fuels' planned Series A preferred equity financing ("Series A Financing"), subject to a $700 million valuation cap ("Investment"). The purchase price includes $1.0 million in cash and $13.0 million in the Marathon SAFE Note issued in exchange for payment-in-kind assets comprised of equipment, related intellectual properties, and other materials located at Marathon's former renewable fuel demonstration facility in Madison, Wisconsin ("Payment-In-Kind Assets"), on and subject to the terms and conditions of the applicable transaction documents ("Investment Agreements"). On *February 28, 2025,* the Payment-In-Kind Assets were transferred to the Company. The Payment-In-Kind Assets were valued based on the fair value of the Marathon SAFE Note, which was recorded as a liability on the condensed consolidated balance sheet as of *June 30, 2025*. The fair value of the SAFE was determined to be $12.0 million, calculated by discounting the $13.0 million principal amount using estimated time periods and a *35%* discount rate (see Note *12*). The cash portion of the Investment will be made within *five* business days of the execution by Comstock Fuels of *third*-party investment agreements for at least $25,000,000 in planned Series A Financing cash proceeds. The Investment Agreements included (i) a simple agreement for future equity governing the portion of the Investment issued in exchange for the Payment-In-Kind Assets; (ii) an asset transfer agreement to assign the Payment-In-Kind Assets; (iii) a license agreement covering applicable intellectual properties ("License Agreement"); and (iv) a letter agreement to provide post-closing conditions ("Letter Agreement"). Ancillary agreements delivered in connection with the Investment Agreements included a board observer agreement executed as of the Effective Date by and between Comstock Fuels and MPC Investment LLC ("MPC"), a subsidiary of Marathon, under which Comstock Fuels granted MPC board observation rights in connection with the Investment ("Board Observer Agreement"). Separately, Comstock Fuels executed a commercial lease agreement for Marathon's former renewable fuels facility located in Madison, Wisconsin ("Madison Facility") (see Note *8*).

<u>License Agreement</u>

Comstock Fuels will use the Madison Facility to increase Comstock Fuels' current pilot production capabilities, including the integration of those facilities with the existing facilities in Wausau, Wisconsin, leveraging Comstock Fuels' patented, patent pending, and proprietary lignocellulosic biomass refining technologies ("Comstock IP"). The License Agreement provides for the grant by Virent to Comstock Fuels of a non-exclusive, non-transferable, non-assignable, non-sublicensable, perpetual, royalty-free license under the Virent IP solely for research and development purposes associated with the Virent equipment ("Included Virent IP"), excluding applications involving the heterogenous catalysis of biomass-derived sugars ("Reserved License Field"). The License Agreement provides for Virent and Comstock Fuels to coordinate in good faith to obtain an additional license for the Reserved License Field for research and development purposes. Comstock also granted Marathon a reciprocal royalty-free, non-exclusive, sublicensable worldwide license to any improvements or additional intellectual property related to the Included Virent IP, excluding improvements to Comstock IP. The parties additionally agreed to negotiate in good faith for a commercial license in the event that a commercial opportunity is identified for the Included Virent IP, and Virent granted Comstock Fuels a right of *first* refusal in the event that Virent transfers some or all of the Included Virent IP to a *third* party, subject to applicable pre-existing rights held by *third* parties. The Virent IP consists of the transfer of know-how in order to use the Payment-In-Kind Assets and does *not* represent any standalone value to the Company, thus, *no* value was assigned to the Virent IP as of *June 30, 2025*.

<u>Letter Agreement</u>

The Letter Agreement requires the cash portion of the Investment to be made within *five* business days of the execution by Comstock Fuels of *third*-party investment agreements for at least $25,000,000 in Series A equity financing. The Letter Agreement additionally requires Comstock Fuels to grant Virent a lien on the Virent Equipment if Comstock Fuels does *not* complete $25,000,000 in the Series A equity financing within *nine* months of the Effective Date. The Letter Agreement additionally reiterated certain elements of the *February 6, 2025,* term sheet by and between the Company, (i) a definitive offtake agreement under which Marathon or its affiliates will purchase advanced biomass-based intermediates and fuels from Comstock Fuels' planned commercial demonstration facility; and (ii) a joint development agreement under which Marathon or its affiliates will provide support services to Comstock Fuels in exchange for a warrant which creates the option for Marathon to purchase additional equity in Comstock Fuels. As of *June 30, 2025*, *$20.0* million of Series A equity financing has been completed.

OTHER

The Company agreed to pay each of the independent directors a total of $160,000 annually, in cash or shares of common stock, which includes an annual cash payment of $60,000 plus chair and committee meeting fees. The Chair of each Committee is paid an additional cash payment of $20,000 annually. For the *three*-months ended *June 30, 2025* and *2024*, the Company recognized director fees expenses of $200,000 and $200,000, respectively. For the *six*-months ended *June 30, 2025* and *2024*, the Company recognized director fees expenses of $400,000 and $425,000, respectively. As of *June 30, 2025* and *December 31, 2024,* director fees compensation included in accounts payable on the condensed consolidated balance sheet was $107,500 and $177,500, respectively. As of *June 30, 2025* and *December 31, 2024,* the Company accrued $1,250,000 and $1,000,000, respectively, in director fee compensation associated with the director fees payable expected to be satisfied with shares of the company's common stock that is expected to be issued in *2025* and paid annually and is included in other long-term liabilities on the condensed consolidated balance sheet.

We are involved in claims and proceedings that arise in the ordinary course of business. There are *no* matters pending that we expect to have a material adverse impact on our business, results of operations, financial condition or cash flows.

**NOTE *11* EQUITY**

*Issuance of Registered Shares of Common Stock*

<u>*2025* Issuances*</u>

On *February 3, 2025,* the Company issued 66,035 registered shares of its common stock for debt-issuance costs equal to 3% of the principal amount of the *2025* Kips Bay Note with a fair value of $319,149 (see Note *9*).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *23*

------

[**Table of Contents**](#toc)

*Issuance of Unregistered Shares of Common Stock* 

<u>*2025* Issuances*</u> 

During the *six*-months ended *June 30, 2025*, the Company issued 93,059 shares of unregistered restricted shares of its common stock with a fair value of $284,526 to Alvin Fund LLC in lieu of payment of interest under the Alvin Fund *2022* and *2023* Notes (see Note *9*).

During the *six*-months ended *June 30, 2025*, pursuant to the *2025* Kips Bay Note, the Company issued 4,120,225 shares of the Company's common stock to Kips Bay with a fair value of $10,739,742 at an average conversion price of $2.61 (see Note *9*).

On *June 12, 2025,* the Company issued 200,000 shares of unregistered restricted shares of its common stock with a fair value of $700,000 to Decommissioning Services in accordance with the Amended Agreement (see Note *8*).

On *June 10, 2025,* the Company issued 2,000,000 shares of unregistered restricted shares of its common stock with a fair value of $5,780,000 to Flux Photon Corporation and affiliates in accordance with the Amendment to the FPC Asset Purchase Agreement (see Notes *6* and *12*).

On *May 13, 2025,* the Company executed subscription agreements with *two* investors for private placement and issued 625,000 shares of unregistered restricted shares of its common stock for $1,500,000.

On *March 20, 2025,* the Company issued 985,000 shares of unregistered restricted shares of its common stock with a fair value of $2,482,200 to American Science and Technology Corporation in accordance with the lease amendment (see Note *8*).

On *February 28, 2025,* the Company issued 775,000 shares of unregistered restricted shares of its common stock with a fair value of $1,860,000 to the Former LINICO CEO in accordance with a LINICO acquisition-related payable (see Note *7*).

On *January 27, 2025,* the Company issued 44,024 shares of unregistered restricted shares of its common stock for debt-issuance costs equal to 2% of the principal amount of the *2025* Kips Bay Note with a fair value of $212,766 (see Note *9*).

<u>*2024* Issuances*</u>

During the *six*-months ended *June 30, 2024*, the Company issued 61,502 shares of unregistered restricted shares of its common stock with a fair value of $240,066 to Alvin Fund LLC in lieu of payment of interest under the Alvin Fund *2022* and *2023* Notes (see Note *9*).

On *May 22, 2024,* the Company issued 125,000 shares of restricted common stock of the Company to our chief executive officer for $500,000 (see Note *15*).

On *April 19, 2024,* the Company issued 100,000 shares of restricted unregistered common stock to a single investor for $250,000.

On *April 19, 2024,* the Company issued 56,101 restricted common stock of the Company for a fair value of $162,693 to a professional services firm for consideration related to the Company's marketing services agreement.

On *April 11, 2024,* pursuant to the amendment in connection with the Haywood lease, the Company issued 150,000 shares of common stock of the Company to Decommissioning Services with a fair value of $509,850 (see Note *8*).

On *April 10, 2024,* pursuant to the AST License Agreement Amendments, the Company issued 497,500 shares of common stock of the Company to AST with a fair value of $1,587,025 (see Note *8*).

On *March 27, 2024,* the Company issued 25,000 shares of unregistered restricted common stock with a fair value of $85,000 to ClearThink as payment for commitment fees under the *2024* ClearThink Agreement.

On *January 11, 2024,* the Company issued 30,893 restricted shares of its common stock for debt-issuance costs with a fair value of $157,895 (see Note *9*).

*Noncontrolling Interest*

For consolidated entities in which our ownership is less than *100%,* we record a non-controlling interest as a component of equity on the condensed consolidated balance sheets, which represents the *third*-party ownership in the net assets of the respective consolidated subsidiary. Additionally, the portion of the net income or loss attributable to the non-controlling interest is reported as net income (loss) attributable to non-controlling interest on the condensed consolidated statements of operations. Changes in ownership interests in an entity that do *not* result in deconsolidation are generally recognized within equity.

On *May 22, 2025,* Bioleum, entered into an agreement with an investor to close on the *first* $20 million in direct Convertible Preferred Stock - Series A equity investment. As part of the agreement, the investor received equity in Bioleum and the Company recognized non-controlling equity interest and additional paid in capital of $663,638 and $19,336,362, respectively, in our condensed consolidated balance sheet. On *May 22, 2025,* Bioleum issued 2.0 million Series *2* Convertible Preferred Shares to the Founder Group in exchange for the assignment of additional developed technologies. As part of the exchange, the Founder Group received equity in Bioleum and the Company determined that the fair value of the Bioleum shares assigned to the Founder Group was $5,280,000 (see Note *12*) which was recognized as an intangible asset and non-controlling equity interest and additional paid in capital of $2,636,382 and $2,643,618, respectively, in our condensed consolidated balance sheet (see Note *6*). The Company attributes Bioleum earnings and losses to non-controlling interests using the hypothetical-liquidation book value ("HLBV") method, which is a balance sheet-oriented approach. Under the HLBV method, Bioleum income and losses are attributed to each unit based on changes to the amounts that each unit would hypothetically receive at each period end under the liquidation provisions of the Bioleum Amended and Restated Certificate of Incorporation, assuming the net assets of Bioleum were liquidated at their carrying values determined in accordance with GAAP. The proportion of earnings and losses attributed to non-controlling interests under HLBV is subject to change as Bioleum net assets change. As of *June 30, 2025*, the Company's preference from the Series *1* Convertible Preferred Shares exceeds Bioleum's net assets. As a result, earnings and losses of Bioleum are fully attributed to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *24*

------

[**Table of Contents**](#toc)

On *March 1, 2023,* Comstock Metals LLC ("Comstock Metals"), a wholly owned subsidiary of the Company, entered into an Employment Agreement with the President of Comstock Metals ("Metals President"). As part of this agreement, the Metals President was to receive 20% of the equity in Comstock Metals, vesting evenly, over a *five*-year period which commenced on *March 1, 2023* through *March 1, 2028.* On *March 1, 2024,* the *first* tranche vested reducing the Company's ownership in Comstock Metals to 96% with a non-controlling interest of 4%. On *December 30, 2024,* Comstock Metals the Metals President entered into a Rescission Agreement to rescind the Employment Agreement and cancel the Metals President vesting of equity in Comstock Metals. The rescission resulted in a decrease in non-controlling interest and a corresponding increase to additional paid in capital of $91,156 during the year ended *December 31, 2024.* For the *three* and *six*-months ended *June 30, 2024*, the Company recognized share-based compensation expense of $43,150 and $86,300, respectively, associated with the rescinded agreement. During *2025,* the Company did not recognize share-based compensation expense associated with the rescinded agreement. As of *June 30, 2025* and *December 31, 2024,* the Company owned 100% of Comstock Metals.

*Warrants*

Outstanding warrants at *June 30, 2025* and *December 31, 2024* are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | ***Number of Warrants*** | ***Exercise Price*** | ***Expiration Date*** |
| GHF, Inc. | 20000 | $4.56 | December 31, 2025 |
| GHF, Inc. | 50000 | $4.56 | December 31, 2025 |
| GHF, Inc. | 50000 | $4.56 | December 31, 2025 |
| Alvin Fund LLC | 100000 | $4.56 | December 31, 2025 |
| Total Outstanding warrants | 220000 |  |  |

---

During the *six*-months ended *June 30, 2025* and *2024*, no warrants to purchase common stock were issued, exercised, or expired.

**NOTE *12***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; **FAIR VALUE MEASUREMENTS**

The following table presents our assets and liabilities measured at fair value on a recurring basis at *June 30, 2025*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | ***Fair Value Measurements at*** | ***Fair Value Measurements at*** | ***Fair Value Measurements at*** |
|  |  | ***June 30, 2025*** | ***June 30, 2025*** | ***June 30, 2025*** |
|  |  | ***Quoted*** | ***Significant*** |  |
|  |  | ***Prices*** | ***Other*** | ***Significant*** |
|  |  | ***in Active*** | ***Observable*** | ***Unobservable*** |
|  |  | ***Markets*** | ***Inputs*** | ***Inputs*** |
|  | ***Total*** | ***(Level 1)*** | ***(Level 2)*** | ***(Level 3)*** |
| **Assets:** |  |  |  |  |
| Haywood derivative | $617167 | $— | $617167 | $— |
| Total assets measured at fair value | $617167 | $— | $617167 | $— |
| **Liabilities:** |  |  |  |  |
| 2025 Kips Bay convertible debt derivative | $220000 | $— | $— | $220000 |
| FPC derivative | 3557000 |  | 3557000 |  |
| Marathon SAFE Note | 12000000 |  |  | 12000000 |
| Total liabilities measured at fair value | $15777000 | $— | $3557000 | $12220000 |

---

The following table presents our assets measured at fair value on a recurring basis at *December 31, 2024*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | ***Fair Value Measurements at*** | ***Fair Value Measurements at*** | ***Fair Value Measurements at*** |
|  |  | ***December 31, 2024*** | ***December 31, 2024*** | ***December 31, 2024*** |
|  |  | ***Quoted*** | ***Significant*** |  |
|  |  | ***Prices*** | ***Other*** | ***Significant*** |
|  |  | ***in Active*** | ***Observable*** | ***Unobservable*** |
|  |  | ***Markets*** | ***Inputs*** | ***Inputs*** |
|  | ***Total*** | ***(Level 1)*** | ***(Level 2)*** | ***(Level 3)*** |
| **Assets:** |  |  |  |  |
| Haywood derivative | $1529850 | $— | $1529850 | $— |
| Total assets measured at fair value | $1529850 | $— | $1529850 | $— |

---

VALUATION METHODOLOGIES

Following is a description of the valuation methodologies used for the Company's financial instruments measured at fair value on a recurring basis as well as the general classification of such instruments pursuant to the valuation hierarchy.

*Derivatives*

The Company has several derivatives associated with its common stock including make-whole commitments and debt conversion options. The following tables presents changes in our derivative assets and liabilities for the *three* and *six*-months ended *June 30, 2025* and *2024*, measured at fair value:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *25*

------

[**Table of Contents**](#toc)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | ***For the Three-Months Ended June 30, 2025*** | ***For the Three-Months Ended June 30, 2025*** | ***For the Three-Months Ended June 30, 2025*** | ***For the Three-Months Ended June 30, 2025*** | ***For the Three-Months Ended June 30, 2025*** |
|  | ***As of March 31, 2025*** | ***(Additions) Deductions*** | ***Change in Fair Value*** | ***Payments for Decrease in Contractual Stock Consideration*** | ***As of June 30, 2025*** |
| 2025 Kips Bay convertible debt derivative | $(920000) | $527963 | $172037 | $— | $(220000) |
| FPC derivative |  | (5087000) | 1530000 |  | (3557000) |
| LINICO acquisition-related payable derivative | (309000) | (60170) | 369170 |  |  |
| AST derivative | 392000 | (1396744) | 1004744 |  |  |
| Haywood derivative | 14942 | 700000 | (207775) | 110000 | 617167 |
| Total derivative assets (liabilities) at fair value | $(822058) | $*(5315951*) | $*2868176* | $*110000* | $*(3159833*) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | ***For the Six-Months Ended June 30, 2025*** | ***For the Six-Months Ended June 30, 2025*** | ***For the Six-Months Ended June 30, 2025*** | ***For the Six-Months Ended June 30, 2025*** | ***For the Six-Months Ended June 30, 2025*** |
|  | ***As of December 31, 2024*** | ***(Additions) Deductions*** | ***Change in Fair Value*** | ***Payments for Decrease in Contractual Stock Consideration*** | ***As of June 30, 2025*** |
| 2025 Kips Bay convertible debt derivative | $— | $(893682) | $673682 | $— | $(220000) |
| FPC derivative |  | (5087000) | 1530000 |  | (3557000) |
| LINICO acquisition-related payable derivative |  | (400170) | 400170 |  |  |
| AST derivative |  | (916204) | 916204 |  |  |
| Haywood derivative | 1529850 | 700000 | (1842683) | 230000 | 617167 |
| Total derivative assets (liabilities) at fair value | $1529850 | $(6597056) | $1677373 | $230000 | $(3159833) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | ***For the Three-Months Ended June 30, 2024*** | ***For the Three-Months Ended June 30, 2024*** | ***For the Three-Months Ended June 30, 2024*** | ***For the Three-Months Ended June 30, 2024*** | ***For the Three-Months Ended June 30, 2024*** |
|  | ***As of March 31, 2024*** | ***(Additions) Deductions*** | ***Change in Fair Value*** | ***Payments for Decrease in Contractual Stock Consideration*** | ***As of June 30, 2024*** |
| 2023 Kips Bay convertible debt derivative | $(1440000) | $430520 | $539480 | $— | $(470000) |
| LINICO acquisition-related payable derivative | (2893325) |  | (359104) |  | (3252429) |
| Haywood derivative | (1160000) | 409850 | (48000) | 120000 | (678150) |
| GenMat derivative | 240478 | (694970) | (209872) | 664364 |  |
| Total derivative assets (liabilities) at fair value | $(5252847) | $145400 | $(77496) | $784364 | $(4400579) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | ***For the Six-Months Ended June 30, 2024*** | ***For the Six-Months Ended June 30, 2024*** | ***For the Six-Months Ended June 30, 2024*** | ***For the Six-Months Ended June 30, 2024*** | ***For the Six-Months Ended June 30, 2024*** |
|  | ***As of December 31, 2023*** | ***(Additions) Deductions*** | ***Change in Fair Value*** | ***Payments for Decrease in Contractual Stock Consideration*** | ***As of June 30, 2024*** |
| 2023 Kips Bay convertible debt derivative | $(1360000) | $(166081) | $1056081 | $— | $(470000) |
| LINICO acquisition-related payable derivative | (2383162) |  | (869267) |  | (3252429) |
| Haywood derivative | (875000) | 409850 | (333000) | 120000 | (678150) |
| GenMat derivative | (781966) | (694970) | (687428) | 2164364 |  |
| Total derivative assets (liabilities) at fair value | $(5400128) | $(451201) | $(833614) | $2284364 | $(4400579) |

---

At *June 30, 2025* and *December 31, 2024*, the fair value of the Haywood derivative asset and derivative liabilities (FPC and Kips Bay) were based on a trading price of the Company's shares of $3.79, and $8.00, respectively. At *June 30, 2024*, fair value of the LINICO and the Haywood derivatives were based on a trading price of the Company's shares of $1.60.

<u>*2025* Kips Bay Select LP Conversion Option</u>

On *January 10, 2025,* the Company recorded a derivative liability on the condensed consolidated balance sheets in connection with the Kips Bay Note. On that date, the $1,700,000 fair value of the derivative liability was determined based on the bifurcation of the derivative liability from the convertible note. The derivative was valued using a Monte Carlo valuation model with a conversion price equal to 88% of the *7*-day minimum VWAP, discount rate of 35%, risk free rate of 4.24%, and volatility of 103.0%. On *March 11, 2025,* the Company bifurcated the conversion feature for the *second* $5.0 million tranche and recorded a derivative liability with a corresponding additional to debt discount of $220,000 reflected in our condensed consolidated balance sheet. The derivative for the *second* tranche was valued using a Monte Carlo valuation model with a conversion price equal to 88% of the *7*-day minimum VWAP, discount rate of 35% risk free rate of 3.98%, and volatility of 126.0%.

During the *three* and *six*-months ended *June 30, 2025*, the Company recorded a gain of $172,037 and $673,682, respectively, for the change in the fair value of the derivative. During *six*-months ended *June 30, 2025*, $1,026,319 of the derivative liability decreased in connection with the conversion of the related debt into shares of common stock. The derivative liability was classified within Level *3* of the valuation hierarchy.

In *2025,* the range of variables used to calculate the original fair value of the conversion option derivative and the fair value on the dates of conversion are as follows.

---

| | | | |
|:---|:---|:---|:---|
| **Stock Price** | ***Discount Rate*** | ***Volatility*** | ***Risk Free Rate*** |
| Conversion price equal to 88% of the 7 day minimum VWAP | 35% | 103.0% to 134.0% | 3.93% to 4.24% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *26*

------

[**Table of Contents**](#toc)

<u>FPC Derivative Instrument</u>

On *May 21, 2025,* in connection with execution and delivery of the Bioleum Transaction Documents, the Company and FPC entered into the FPC Asset Purchase Agreement Amendment and issued 2,000,000 shares of common shares of the Company, 1,700,000 of such shares will go towards settling $10.0 million of the Earn Out, with true up provisions for any proceeds received by FPC that are below or in excess of *$10.0* million (see Note *6*). The Company further agreed to register the Company's common stock for resale by Flux under the Securities Act of *1933,* as amended, which became effective on *June 30, 2025.*

The Company issued FPC 1,700,000 shares of its common stock with a fair value of $4,913,000 and recorded a derivative liability of $5,087,000 based on the *$2.89* closing price per share of our common stock. The settlement is designed to fully satisfy the existing obligation of $10.0 million. During the *three* and *six*-months ended *June 30, 2025,* the Company recorded a gain of $1,530,000 for the change in the fair value of the derivative. The derivative liability was classified within Level *2* of the valuation hierarchy.

<u>LINICO Acquisition-Related Payable Derivative Instrument</u>

On *February 28, 2025,* the Company agreed to make cash payments of $148,853 and issue common shares of the Company valued at $2,200,000 to settle all amounts payable for the acquisition of LINICO to the Former LINICO CEO in full (see Note *7*). The Company agreed to make up any shortfall if the proceeds from the sale of the shares are less than $2.2 million, and Former LINICO CEO agreed to refund any excess proceeds. In *March 2025,* the Company issued to Former LINICO CEO 775,000 shares of its common stock with a fair value $1,860,000 and recorded a derivative liability of $340,000. The Company further agreed to register the Company's common stock for resale by Former LINICO CEO under the Securities Act of *1933,* as amended, which became effective on *March 28, 2025.* The settlement is designed to fully satisfy the existing obligation of over $3.2 million and resulted in an estimated gain of $845,000 reflected in gain on extinguishment of liability on our condensed consolidated statement of operations. During the *three* and *six*-months ended *June 30, 2025*, the Company recorded a gain of $369,170 and $400,170, respectively, for the change in the fair value of the derivative. The derivative liability was classified within Level *2* of the valuation hierarchy. At *June 30, 2025*, the Company fulfilled our commitment requirements which satisfied the make-whole provision and removed the requirement to account for the commitment as a derivative.

<u>AST Derivative Instrument</u>

On *March 20, 2025,* the Company recognized a derivative asset on the condensed consolidated balance sheets in connection with the Second License Agreement Amendments (see Note *8*). On that date, the $480,540 fair value of the derivative asset was determined based on the excess of the fair value of 1,207,166 shares of our common stock issued to and held by AST over the $3.5 million contractual stock consideration required under the agreement. The value of the shares was based on the $2.52 closing price per share of our common stock on that date. The Company further agreed to register the Company's common stock for resale by AST under the Securities Act of *1933,* as amended, which became effective on *April 7, 2025.* At *June 30, 2025*, the fair value of the Company's common stock held by AST of 154,656 shares was based on the closing price per share of our common stock with a fair value of the receivable of $437,677 (see Note *8*). During the *three* and *six*-months ended *June 30, 2025*, the Company recorded a gain of $1,004,744 and $916,204, respectively, for the change in the fair value of the derivative. The derivative asset was classified in Level *2* of the valuation hierarchy. At *June 30, 2025*, the Company fulfilled our commitment requirements which satisfied the make-whole provision and removed the requirement to account for the commitment as a derivative.

<u>Haywood Derivative Instrument</u>

On *April 7, 2022,* the Company recognized a derivative asset on the condensed consolidated balance sheets in connection with the lease from Haywood (see Note *8*). On that date, the $245,000 fair value of the derivative asset was determined based on the excess of the fair value of 150,000 shares of our common stock issued to and held by Haywood and a deposit of $50,000 over the initial $2,100,000 contractual stock consideration required under the agreement. The agreement was amended in *2024* (see Note *8*) increasing the commitment by $100,000 from $2.1 million to $2.2 million. On *April 11, 2024,* the Company issued an additional 150,000 shares of our common stock to Haywood in accordance with the amendment which has a fair value of $509,850 at the closing price of $3.40. On *June 9, 2025,* the agreement was amended and the Company issued an additional 200,000 shares of our common stock to Haywood in accordance with the amendment which has a fair value of $700,000 at the closing price of $3.50 (see Note *8*).

During the *six*-months ended *June 30, 2025* and the year-ended *December 31, 2024,* the Company paid Haywood $230,000 and $420,000, respectively, which resulted in a decrease in contractual stock consideration. As of *June 30, 2025*, Decommissioning Services sold 290,000 shares of the Company's stock for net proceeds of $971,268. At *June 30, 2025*, the fair value of the 210,000 shares was based on the closing price per share of our common stock of $3.79 and the fair value of the derivative asset was $617,167. During the *three* and *six*-months ended *June 30, 2025*, the Company recorded a loss of $207,775 and $1,842,683, respectively, for the change in the fair value of the derivative. The derivative asset is classified within Level *2* of the valuation hierarchy.

<u>Marathon SAFE Note Instrument</u> 

On *February 28, 2025,* Comstock Fuels entered into a series of definitive agreements with Virent, involving the purchase of Comstock Fuels equity as part of Comstock Fuels' planned Series A Financing (see Notes *5* and *10*). At *March 31, 2025,* the Company recognized the Marathon SAFE Note liability of $12.0 million on the condensed consolidated balance sheets in connection with the agreement with Virent and elected to account the Marathon SAFE Note liability under the fair value option. The Marathon SAFE Note liability was estimated with assistance from *third*-party valuation specialists and valued using a probability weighted present value of the Marathon SAFE Note with the discount factor based on published venture capital rate of returns of 35% and a discounting period range of 0.25 to 0.84 years. At *June 30, 2025*, the Marathon SAFE Note liability was estimated at $12.0 million and valued using a probability weighted present value of the Marathon SAFE Note with the discount factor based on published venture capital rate of returns of 35% and a discounting period range of 0.25 to 0.75 years. The Marathon SAFE Notes' fair value as of *June 30, 2025,* remains the same as its initial valuation, primarily given the short period until its expected redemption. The Marathon SAFE Note liability was classified within Level *3* of the valuation hierarchy.

<u>Founders Shares</u>

The Founder Group received equity in Bioleum (see Notes *6* and *11*) and the fair value of the Founders Shares were estimated with assistance from *third*-party valuation specialists and valued using a historical cost approach and an option pricing analysis of the Founders Shares with the discount factor based on published venture capital rate of returns of 50%, an option term of 5 years, a risk-free rate of 4.11%, a marketability discount of 40% and peer volatility of 108%. The Founders Shares were classified within Level *3* of the valuation hierarchy. The initial fair value determination of the Founder Shares at the date of issuance is a non-recurring event.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *27*

------

[**Table of Contents**](#toc)

*Other Financial Instruments*

At *June 30, 2025*, the carrying amount of cash and cash equivalents, notes receivable and debt carried at amortized costs, approximates fair value because of the short-term maturity of these financial instruments.

**NOTE *13* NET INCOME (LOSS) PER COMMON SHARE**

Basic earnings per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of shares of common stock outstanding during the period. Diluted income (loss) per share reflects the potential dilution that could occur if outstanding stock options were exercised into common stock. Shares presented on a weighted average outstanding calculation were adjusted to give effect to the *February 24, 2025* reverse stock split.

Net income (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of shares of common stock outstanding during the period. For the *three* and *six*-months ended *June 30, 2025* and *2024*, all common stock equivalent shares, including warrants to purchase common stocks and a conversion option on a convertible debt, are antidilutive.

**NOTE *14* SEGMENT REPORTING** 

We have the following segments and reporting units: Fuels, Metals, Mining, Strategic Investments and Corporate. The Company's goal is to accelerate the commercialization of decarbonizing technologies. Once a technology achieves a certain technology readiness or a justifiable critical mass or market distinction, we strategically plan its commercialization and dedicate resources toward that end. Until then, it is managed with corporate resources.

Summarized financial information relating to our reportable segments is provided below. Our chief operating decision maker ("CODM") is our executive team consisting of our chief executive officer, chief operating officer and chief technology officer. Our CODM assesses the Company's performance and allocation of capital resources based on our segments of Fuels, Metals, Mining, Strategic Investments and Corporate. Certain amounts have been reclassified to conform to the current period presentation on a comparable basis. The Company plans, executes and monitors each reporting segment and has dedicated personnel responsible for each reportable segment. Our Fuels Segment represents our lignocellulosic biomass into biointermediates for refining into renewable fuels. Our Metals Segment represents our recycling of electrification products. Our Mining Segment includes our gold and silver mining assets and related real estate. Our Strategic Investments Segment includes our investments in Green Li-ion and SSOF and our Corporate Segment includes all other assets and general corporate costs. Mining revenue is from leasing mineral claims and other real estate.

The Company's total revenue for the *three*-months ended *June 30, 2025*, consisted of the following:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  | ***Strategic*** |  |  |
|  | ***Fuels*** | ***Metals*** | ***Mining*** | ***Investments*** | ***Corporate*** | ***Total*** |
| Mining and Real Estate | $— | $— | $32250 | $— | $4300 | $36550 |
| Decommissioning Services |  | 296789 |  |  |  | 296789 |
| Off-take |  | 6207 |  |  |  | 6207 |
| Total Revenue | $— | $302996 | $32250 | $— | $4300 | $339546 |

---

The Company's total revenue for the *three*-months ended *June 30, 2024*, consisted of the following:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  | ***Strategic*** |  |  |
|  | ***Fuels*** | ***Metals*** | ***Mining*** | ***Investments*** | ***Corporate*** | ***Total*** |
| Mining and Real Estate | $— | $— | $422425 | $— | $4800 | $427225 |
| Recycling |  | 7599 |  |  |  | 7599 |
| Total Revenue | $— | $7599 | $422425 | $— | $4800 | $434824 |

---

The Company's total revenue for the *six*-months ended *June 30, 2025*, consisted of the following:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  | ***Strategic*** |  |  |
|  | ***Fuels*** | ***Metals*** | ***Mining*** | ***Investments*** | ***Corporate*** | ***Total*** |
| Mining and Real Estate | $*—* | $— | $64500 | $*—* | $9100 | $73600 |
| Decommissioning Services | *—* | 1040701 | *—* | *—* | *—* | 1040701 |
| Off-take | *—* | 11060 | *—* | *—* | *—* | 11060 |
| Total Revenue | $*—* | $1051761 | $64500 | $*—* | $9100 | $1125361 |

---

The Company's total revenue for the *six*-months ended *June 30, 2024*, consisted of the following:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  | ***Strategic*** |  |  |
|  | ***Fuels*** | ***Metals*** | ***Mining*** | ***Investments*** | ***Corporate*** | ***Total*** |
| Mining and Real Estate | $— | $— | $843576 | $— | $9600 | $853176 |
| Recycling |  | 7599 |  |  |  | 7599 |
| Total Revenue | $— | $7599 | $843576 | $— | $9600 | $860775 |

---

For the *six*-months ended *June 30, 2025*, one customer, RWE, accounted for over *10%* of our revenues. For the *six*-months ended *June 30, 2024*, one customer, Mackay Precious Metals Inc., accounted for over *10%* of our revenues. At *June 30, 2025*, two customers, RWE and Mackay Precious Metals Inc., accounted for over *10%* of our accounts receivable balance. At *December 31, 2024,* one customer, Mackay Precious Metals Inc., accounted for over *10%* of our accounts receivable balance. At *June 30, 2025*, Comstock Metals billed $2.31 million of which $1.05 million was for decommissioning services and recorded as revenue and $1.1 million of which represents fees for recycling services that have *not* yet been completed and are recognized a deferred revenue. As of *June 30, 2025*, total deferred revenue for these services were $1.40 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *28*

------

[**Table of Contents**](#toc)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Three-Months Ended** |  |  |  |  |  |  |
| **June 30, 2025** | ***Fuels*** | ***Metals*** | ***Mining*** | ***Strategic Investments*** | ***Corporate / Other*** | ***Total*** |
| Revenue | $— | $302996 | $32250 | $— | $4300 | $339546 |
| Cost of goods sold | $— | $814001 | $— | $— | $— | $814001 |
| Selling and marketing | $121901 | $11806 | $— | $— | $137844 | $271551 |
| General and administrative | $1373335 | $703087 | $420519 | $4076 | $1862522 | $4363539 |
| Research and development | $1922056 | $36175 | $316 | $— | $162098 | $2120645 |
| Depreciation and amortization | $508450 | $63510 | $45335 | $— | $19397 | $636692 |
| Gain on sale of mineral rights | $— | $— | $(200000) | $— | $— | $(200000) |
| Loss from operations | $(3925742) | $(1325583) | $(233920) | $(4076) | $(2177561) | $(7666882) |
| Total other income (expense), net | $963112 | $— | $(153692) | $369170 | $(1338651) | $(160061) |
| Net income (loss) | $(2962630) | $(1325583) | $(387612) | $365094 | $(3516212) | $(7826943) |
| Interest Expense | $102336 | $— | $874 | $— | $670852 | $774062 |
| Equity method investment income (loss) | $(24000) | $— | $— | $— | $— | $(24000) |
| Acquisition of intangible assets | $20735617 | $— | $— | $— | $— | $20735617 |
| Capital Expenditures | $396530 | $72169 | $— | $— | $— | $468699 |
| Total Assets as of June 30, 2025 | $67126128 | $7631702 | $27030322 | $45278423 | $1150382 | $148216957 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Three-Months Ended** |  |  |  |  |  |  |
| **June 30, 2024** | ***Fuels*** | ***Metals*** | ***Mining*** | ***Strategic Investments*** | ***Corporate / Other*** | ***Total*** |
| Revenue | $— | $7599 | $422425 | $— | $4800 | $434824 |
| Selling and marketing | $1450 | $5054 | $— | $— | $183985 | $190489 |
| General and administrative | $(6224) | $230952 | $470756 | $3659 | $1903190 | $2602333 |
| Research and development | $2116792 | $170443 | $— | $1287 | $259945 | $2548467 |
| Depreciation and amortization | $235260 | $358427 | $45158 | $270 | $17602 | $656717 |
| Income (loss) from operations | $(2347278) | $(757277) | $(93489) | $(5216) | $(2359922) | $(5563182) |
| Total other income (expense), net | $(117895) | $— | $32169 | $(775912) | $(2227452) | $(3089090) |
| Net loss | $(2465173) | $(757277) | $(61320) | $(781128) | $(4587374) | $(8652272) |
| Interest Expense | $70192 | $— | $2143 | $— | $710105 | $782440 |
| Equity method investment income (loss) | $(48400) | $— | $6054 | $(606935) | $— | $(649281) |
| Capital Expenditures | $— | $109999 | $— | $— | $— | $109999 |
| Total Assets as of December 31, 2024 | $11015850 | $6617437 | $27505049 | $44628544 | $1543001 | $91309881 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *29*

------

[**Table of Contents**](#toc)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Six-Months Ended** |  |  |  |  |  |  |
| **June 30, 2025** | ***Fuels*** | ***Metals*** | ***Mining*** | ***Strategic Investments*** | ***Corporate / Other*** | ***Total*** |
| Revenue | $— | $1051761 | $64500 | $— | $9100 | $1125361 |
| Cost of goods sold | $— | $1700797 | $— | $— | $— | $1700797 |
| Selling and marketing | $122889 | $25350 | $— | $— | $360686 | $508925 |
| General and administrative | $1698168 | $1197638 | $584757 | $5751 | $3898316 | $7384630 |
| Research and development | $4798998 | $72802 | $1757 | $— | $551006 | $5424563 |
| Depreciation and amortization | $756031 | $126129 | $90623 | $— | $39293 | $1012076 |
| Gain on sale of mineral rights | $— | $— | $(200000) | $— | $— | $(200000) |
| Income (loss) from operations | $(7376086) | $(2070955) | $(412637) | $(5751) | $(4840201) | $(14705630) |
| Total other income (expense), net | $838913 | $— | $(1743168) | $400170 | $(1711159) | $(2215244) |
| Net income (loss) | $(6537173) | $(2070955) | $(2155805) | $394419 | $(6551360) | $(16920874) |
| Interest Expense | $187845 | $— | $1795 | $— | $1243566 | $1433206 |
| Equity method investment income (loss) | $17438 | $— | $— | $— | $— | $17438 |
| Acquisitions to intangible assets | $20915617 | $— | $— | $— | $— | $20915617 |
| Capital Expenditures | $430581 | $278991 | $— | $— | $— | $709572 |
| Total Assets as of June 30, 2025 | $67126128 | $7631702 | $27030322 | $45278423 | $1150382 | $148216957 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Six-Months Ended** |  |  |  |  |  |  |
| **June 30, 2024** | ***Fuels*** | ***Metals*** | ***Mining*** | ***Strategic Investments*** | ***Corporate / Other*** | ***Total*** |
| Revenue | $— | $7599 | $843576 | $— | $9600 | $860775 |
| Selling and marketing | $1515 | $5575 | $— | $— | $293457 | $300547 |
| General and administrative | $493225 | $505619 | $835759 | $(83651) | $4268847 | $6019799 |
| Research and development | $2539662 | $257140 | $— | $1287 | $642391 | $3440480 |
| Depreciation and amortization | $472364 | $714313 | $90273 | $540 | $35205 | $1312695 |
| Income (loss) from operations | $(3506766) | $(1475048) | $(82456) | $81824 | $(5230300) | $(10212746) |
| Total other income (expense), net | $(133777) | $— | $(211303) | $(2329825) | $(2682941) | $(5357846) |
| Net income (loss) | $(3640543) | $(1475048) | $(293759) | $(2248001) | $(7913241) | $(15570592) |
| Interest Expense | $86637 | $— | $2143 | $— | $1512322 | $1601102 |
| Equity method investment income (loss) | $(48400) | $— | $(3646) | $(1173139) | $— | $(1225185) |
| Acquisitions to intangible assets | $— | $— | $— | $— | $— | $— |
| Capital Expenditures | $— | $465938 | $— | $— | $— | $465938 |
| Total Assets as of December 31, 2024 | $11015850 | $6617437 | $27505049 | $44628544 | $1543001 | $91309881 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *30*

------

[**Table of Contents**](#toc)

**NOTE *15* RELATED PARTY TRANSACTIONS** 

The following related party transactions occurred during the *six*-months ended *June 30, 2025* and *2024*.

TRANSACTIONS INVOLVING SIERRA SPRINGS OPPORTUNITY FUND

At *June 30, 2025*, the Company's total investment in SSOF has a carrying value of $20,225,000, representing 11,236,111 shares of common stock, or 17.40% of the total SSOF outstanding shares of common stock on a fully diluted, if converted basis. SSOF is a qualified opportunity zone fund, which owns 100% of SSE, a qualified opportunity zone business. SSE and its subsidiaries own or control approximately 2,500 acres of land, a manufacturing facility, significant senior, junior and effluent water rights, sewer rights and also owns and operates the Silver Springs Regional Airport LLC.

The Company's executive chairman and chief executive officer co-founded SSOF and Sierra Springs Enterprises Inc. ("SSE"), and serves as the chief executive officer of SSOF and as an executive of SSE along with a diverse team of qualified financial, capital markets, real estate and operational professionals that together govern, lead and manage SSOF and SSE. Our chief executive officer and *two* of our directors have invested $525,000 into SSOF consistent of 7,671,000 voting shares of SSOF which represents 11.88% of total as converted SSOF shares of common stock. The Company's chief executive officer has *not* received compensation from either SSOF or SSE.

TRANSACTIONS INVOLVING FLUX PHOTON CORPORATION ("FPC")

On *September 7, 2021,* the Company entered into the FPC Asset Purchase Agreement with FPC to acquire the FPC Assets. The purchase price payable for the FPC Assets was $18,000,000 payable in cash to FPC at a rate equal to 20% of the future monthly consolidated sales, less total variable costs, less operating expenses, maintenance, tax payments, and debt service payments of the Company and its now and hereafter-existing subsidiaries, until the purchase price of $18,000,000 has been fully paid. The Company assigned the FPC Assets to the Company immediately after closing. On *December 10, 2021,* the FPC Asset Purchase Agreement was amended to provide for the payment by the Company of a $350,000 down payment against the purchase price, with a remaining performance-based cash payment of $17,650,000 required under the FPC Asset Purchase Agreement. The Company's former chief technology officer and the former president of Comstock Fuels are indirect beneficiaries of all payments made to FPC under the FPC Asset Purchase Agreement. The Company additionally agreed to appoint the Company's former chief technology officer to the Company's Board of Directors in connection with the Company's acquisition of Comstock Innovations Corporation on *September 7, 2021.*

On *December 28, 2023,* the Company entered into an amendment (the *"2023* FPC Asset Purchase Agreement Amendment") with FPC to amend that certain Asset Purchase Agreement, dated on *September 7, 2021,* and amended on *December 10, 2021 (*as amended, the "FPC Asset Purchase Agreement"). Pursuant to the *2021* FPC Asset Purchase Agreement, the Company acquired certain intellectual property and related photocatalysis laboratory equipment (the "FPC Assets"). The original purchase price included a payable for the FPC Assets of $17,650,000, payable only from 20% of future cash flows defined as the future monthly consolidated sales, less total variable costs, less operating expenses, maintenance, tax payments, and debt service payments of the Company and its now and hereafter-existing subsidiaries until the purchase prices has been fully paid. The *2023* FPC Asset Purchase Agreement Amendment reduced the purchase price payable to FPC to $16,850,000. On *December 28, 2023,* the Company paid $200,000 on this payable which was accounted for as an acquisition of intellectual property. The remaining balance of $16,650,000 will be paid to FPC from future cash flows. During *2024,* the Company paid an additional $275,000 to FPC reducing the remaining payable from future cash flows to $16,375,000.

On *May 21, 2025,* in connection with the execution and delivery of the Bioleum Transaction Documents, the Company and FPC entered into the Amendment to the FPC Asset Purchase Agreement and issued 2,000,000 shares of common shares of the Company, 1,700,000 of such shares will go towards settling $10.0 million of the Earn Out, with true up provisions for any proceeds received by FPC that are below or in excess of $10.0 million, and the other 300,000 additional shares of common stock as settlement with certain FPC affiliates (see Note *6*). The Company issued FPC 1,700,000 shares of its common stock with a fair value of $4,913,000 and recorded a derivative liability of $5,087,000 (see Note *12*). The Company further agreed to register the Company's common stock for resale by Flux under the Securities Act of *1933,* as amended, which became effective on *June 30, 2025.* 

BIOLEUM FOUNDERS SHARES

Bioleum issued 2.0 million Series *2* Convertible Preferred Shares to the Founders Group in exchange for the assignment of additional developed technologies (see Notes *2, 6* and *11*). A member of the Founders Group is an immediate family member of the chief executive officer.

PURCHASE OF METAL RECYCLING FURNACE

On *December 15, 2023,* the Company and Comstock Metals, signed an agreement in whereby Comstock Metals contributed a metal recycling furnace to the Company in exchange for $375,000 from an amount *not* exceeding 20% of excess cash flow generated by Comstock Metals, defined as excess cash available after the satisfaction of all planned growth capital for Comstock Metals and the repayment of intercompany loans. At *June 30, 2025* and *December 31, 2024,* the metal recycling furnace is included in Properties, plant and equipment, net and the corresponding liability is included in other liabilities (long- term) on the condensed consolidated balance sheet. For the *three*-months ended *June 30, 2025* and *2024*, the Company recognized depreciation expense on the metal recycling furnace of $4,688. For the *six*-months ended *June 30, 2025* and *2024*, the Company recognized depreciation expense on the metal recycling furnace of $9,376.

OTHER

Sierra Clean Processing LLC, a wholly owned subsidiary of SSOF, owns the building at *600* Lake Avenue, Silver Springs, Nevada which the Company entered into the Building Lease on *August 15, 2023* and a Real Estate and Building Lease on *July 1, 2024 (*see Note *8*). The Company's chief executive officer is an executive officer and director of Sierra Clean Processing LLC.

On *May 17, 2024,* the chief executive officer purchased 125,000 restricted shares of the Company's common stock at a price of $4.00 per share, or $500,000 in net proceeds. Separately, the chief executive officer entered into a personal promissory note with Alvin Fund LLC ("Alvin"), who is separately a creditor and shareholder of the Company. The promissory note has a principal of $1,100,000 and accrues interest at 6% per annum for *one* year and 8% per annum thereafter and matures *three* years from the date of issuance. The obligations under the chief executive officer's personal promissory note are secured by a security interest in SSOF shares owned by the chief executive officer. The chief executive officer assigned 500,000 shares of SSOF owned by him to Alvin as partial consideration for the extension of credit. The Company is *not* a party to the chief executive officer's arrangements with Alvin.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *31*

------

[**Table of Contents**](#toc)

**NOTE *16* SUBSEQUENT EVENTS**

On *August 4, 2025,* the Company issued 19,608 shares of unregistered restricted common stock with a fair value of $63,518 to Alvin Fund in lieu of cash payments from interest under the Alvin *2023* Note.

On *August 4, 2025,* the Company issued *14,843* shares of unregistered restricted common stock with a fair value of *$53,479* to Alvin Fund in lieu of cash payments from interest under the Alvin *2022* Note.

On *August 4, 2025,* the Company issued 132,573 shares of unregistered restricted common stock with a fair value of $482,500 to Northern Comstock LLC as payment for obligations due under the Northern Comstock operating agreement.

On *August 8, 2025,* the Company reached agreement amend its outstanding promissory notes with its creditors, Georges Trust and Alvin Fund LLC. Pursuant to the amendments, the Company issued *2,900,000* shares to such creditors, the proceeds of which will be used by such creditors to pay the $8,390,000 principal amount and interest owed to such creditors. Pursuant to the amendments, on or before *April 15, 2026,* the Company is required to pay such creditors an amount equal to the total amounts payable pursuant to the promissory notes minus the net cash proceeds received the creditors from the sale of the Company's commons shares. Any cash proceeds or shares held after repayment of the promissory notes shall be returned to the Company. The Company is required to file a resale registration statement for the benefit of the creditors.

On *August 12, 2025,* the Company entered into a payoff letter agreement (the "Payoff Agreement"), with Kips Bay Select, LP ("Kips Bay") related to the Company's obligations under its *6.0%* Convertible Promissory Note due *April 10, 2026,* in the original aggregate principal amount of *$10,638,298* (the "Note"). Pursuant to the Payoff Agreement, Kips Bay agreed to accept the payment of *$2,500,000* in cash from the proceeds (the "Cash Payment Amount") and the issuance of *447,724* shares of Common Stock, previously reserved and approved for issuance upon conversion of the Note (the "Payoff Shares"), in full satisfaction of the Company's obligations under the Note (the satisfaction of the Note, the payment of the Cash Payment Amount and the issuance of the Payoff Shares are collectively referred to herein as the "Note Payoff"). In addition, Kips Bay agreed *not* to sell or trade any of the Payoff Shares on or prior to *October 31, 2025.*

On *August 12, 2025,* the Company announced a Confidentially Marketed Public Offering ("CMPO") with Titan Partners. The Company raised *$30* million in gross proceeds before underwriting discounts and commissions and other offering expenses. The Company plans on using the net proceeds from this offering to make (i) a final capital contribution to Northern Comstock in an amount of *$1,412,500,* (ii) a $2,500,000 cash payment to Kips Bay on or before *August 19, 2025, (*iii) up to $12 million for capital expenditures for the Comstock Metals *first* industry scale facility, and other related operating and development expenses associated with commercializing that *first* industry scale facility and the rest for general corporate purposes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *32*

------

[**Table of Contents**](#toc)

**ITEM 2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

*The following discussion and analysis provides information that management believes is relevant to an assessment and understanding of our condensed consolidated financial condition and results of operations. This discussion should be read in conjunction with the Condensed Consolidated Financial Statements, footnotes and the risk factors included herewith and herein.*

OVERVIEW

Comstock innovates and commercializes technologies, systems and supply chains that extract, integrate and convert under-utilized natural and waste resources into clean energy products, including pioneering technologies that produce electrification metals and minerals from end-of-life solar panels, and investments, like Green Li-ion, that produces electrification products from recycled battery waste and Bioleum, that produces renewable fuels from waste, purpose grown energy crops and other forms of woody biomass.

We plan on delivering extraordinary shareholder value by using systemic management practices, disciplined frontier scientific discovery, and applied engineering to innovate, develop, deploy and monetize clean energy technologies with integrated teams and partners in dedicated lines of business, especially in renewable metals. Our plans to generate revenue and throughput involve both using and licensing our technologies, including by creating financial and other incentives to enable and motivate our customers, licensees, and other stakeholders to use their capital, infrastructure, and resources, often integrated directly with us and our solutions, to accelerate and maximize adoption.

We also own and manage investments in related assets that support our businesses, including existing minority equity positions and partnerships in strategic technology developers, two Wisconsin renewable fuels demonstration facilities, and a Nevada solar panel recycling demonstration facility. We also own and manage direct investments in northern Nevada real estate comprised primarily of industrial and commercial land, water rights and about twelve square miles of gold and silver mining claims and surface parcels that we own, lease or have a royalty interest in, some of which contain measured and indicated, and inferred gold and silver resources.

***Lines of Business***

*Metals Segment*

Our Metals segment has established a goal of *Setting the global standard for solar panel recycling*. We have already operated a permitted, demonstration-scale solar panel recycling facility for over 18 months, while it generated $0.4 million in revenue during 2024, we have seen a nearly six-fold increase in our billable revenues (both recognized and deferred) in the first half of 2025, including service fees for decommissioning services, recycling and processing end-of-life solar panels, and offtake sales of high-value recycled materials, including aluminum, copper, glass, and concentrated precious metals. This facility can deliver environmentally superior, zero-landfilled recycling solutions that support U.S. mineral industries and we believe this technology deployment is globally leading and positioned to operate a world-class, quality, global solar panel recycling operation and the Metals system, as a whole, can establish the pace of global solar panel recycling network deployment.

Comstock Metals has initiated additional permitting for its first industry-scale production facility, located on the same campus as the operating demonstration-scale facility, that can scale the operation, up to 100,000 tons per year. This strategically located facility will enable the expeditious transition of proven processes from demonstration to full-scale production. The industry-scale facility is expected to significantly enhance our ability to meet the rapid and continuously growing demand for domestically recovered metals.

Our plan supports the creation of a more robust domestic supply chain for critical materials by innovating and scaling sustainable recycling technologies. The Company plans to build up to seven facilities in the United States over the next five years and support American energy and resource independence while simultaneously delivering significant economic and environmental value.

Our Metals Segment's 2025 objectives include (1) finalizing the industry-scale engineering, (2) submitting all prerequisite permits, (3) closing on equity and/or debt financing for Comstock Metals to sufficiently fund the construction and commissioning of the Company's first industry-scale facility, (4) ordering all of the industry-scale equipment for our first industry-scale facility, (5) securing larger and longer terms supply contracts and (6) accelerating site selection for our second and third facilities.

*Mining Segment*

Our Mining Segment generated income from leases, licenses, and related fees during 2024, and is administered by our wholly owned subsidiaries, Comstock Mining LLC, Comstock Processing LLC and various other local subsidiaries that collectively own, control, or retain royalty interest in twelve square miles of properties of patented mining claims, unpatented mining claims and surface parcels in northern Nevada, including six and a half miles of continuous mineralized strike length (the "Comstock Mineral Estate").

On December 18, 2024, the Company executed a membership interest purchase agreement with Mackay Precious Metals Inc. ("Mackay") pursuant to which the Company sold all of its right, title, and interest in its wholly owned subsidiary Comstock Northern Exploration LLC, and the Company's 25% interest in Pelen Limited Liability Company ("Pelen"), for an aggregate purchase price of $2,750,000. The Northern Targets encompass both the Gold Hill and Occidental Lode claim groups in Storey County, Nevada. Pelen owns certain claims adjacent to and/or relevant to these northern claim groups. The Company was paid $1.0 million in cash in 2024 and was due another $1.75 million in either cash or their publicly registered common stock that is due and payable. On June 6, 2025, the parties executed an amendment (the "First Amendment"), to the membership interest purchase agreement. Pursuant to the First Amendment, the membership interest purchase agreement was amended to increase the purchase price to $2,950,000 bringing all final cash amounts due to a total of $1,950,000. As of June 30, 2025, the Company received cash payments of $572,945 and recognized $1,377,055 in accounts receivable on our condensed consolidated balance sheet. As of August 13, 2025, the Company received additional cash payments of $949,995 with the final $500,000 cash payment due on or before August 30, 2025. For the three and six-months ended June 30, 2025, pursuant to the First Amendment, the Company recognized an additional gain on the sale of mineral rights of $200,000 in our condensed consolidated statement of operations.

On June 30, 2023, the Company has previously entered a Mineral Exploration and Mining Lease Agreement ("Mackay Mining Lease") with Mackay. Since entering the Mackay Mining Lease, the Company has received cash of $3.76 million in initial and ongoing lease payments, including the final pro-rata lease payment associated with these properties. The Mackay Mining Lease terminated on December 18, 2024.

Our Mining Segment's 2025 objectives include (1) monetizing over $2.0 million from the sale of the northern mining claims, (2) advancing the preliminary economic assessment for the Dayton Consolidated Project and (3) the development of preliminary Dayton mine and reclamation plans, progressing toward full economic feasibility for Dayton.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33

------

[**Table of Contents**](#toc)

*Bioleum* 

We hold an investment in Bioleum, through our Preferred Series 1 equity position (see Note 2 to the condensed consolidated financial statements). Bioleum delivers advanced lignocellulosic biomass refining solutions that are setting new industry standards for the production of cellulosic ethanol, gasoline, renewable diesel, sustainable aviation fuel ("SAF"), and other renewable Bioleum™ fuels, with extremely low carbon intensity scores of 15 and market-leading yields of up to 140 gallons per dry metric ton of feedstock (on a gasoline gallon equivalent basis, or "GGE"), depending on feedstock, site conditions, and other process parameters. Bioleum additionally holds the exclusive rights to intellectual properties developed by Hexas, subject to certain preexisting agreements, for production of purpose grown energy crops in liquid fuels applications with proven yields exceeding 25 to 30 dry metric tons per acre per year. The combination of Bioleum's high yielding refining platform and Hexas' high yielding energy crops enables the production of enough feedstock to produce upwards of 100 barrels (at 42 gallons per barrel) of fuel per acre per year, with regenerative practices that can effectively transform marginal agricultural lands into perpetual "drop-in sedimentary oilfields" with the potential to dramatically boost regional energy security and rural economies. Bioleum plans to contribute to domestic energy dominance by directly building, owning, and operating a network of Bioleum refineries in the U.S. to produce about 200 million barrels of renewable fuel per year by 2035, starting with its planned first 400,000 barrel per year commercial demonstration facility in Oklahoma. Bioleum also licenses its advanced feedstock and refining solutions to third parties for additional production in global markets, including several recently announced projects. Bioleum does not currently generate revenue but is anticipated to do so from recently announced agreements for licensing and related engineering services in Australia, Vietnam, and Pakistan.

Bioleum operates two complementary and interdependent pilot facilities, including a feedstock conversion and biointermediate production pilot in Wausau, Wisconsin ("Wausau Facility"), and a biointermediate conversion and renewable fuel production pilot in Madison, Wisconsin ("Madison Facility"). Bioleum continues innovating its existing commercial process for the purpose of increasing its market-leading yields, further decreasing carbon intensities, and driving costs down in pursuit of fossil parity. Bioleum's innovations group has also partnered with National Renewable Energy Laboratory ("NREL"), the Massachusetts Institute of Technology ("MIT"), RenFuel K2B AB ("RenFuel"), Emerging Fuels Technologies Inc. ("EFT"), and others with sponsored research, licensing, and other agreements. Bioleum also partners with Hexas and other strategic operating partners for the same objectives.

Effective February 28, 2025, we effectively entered into a series of definitive agreements with subsidiaries of Marathon Petroleum Corporation ("Marathon"), involving the purchase of $14,000,000 in Bioleum equity as part of the Series A Financing, subject to a $700,000,000 valuation cap ("Investment"). The purchase price includes $1,000,000 in cash and $13,000,000 in payment-in-kind assets comprised of equipment, related intellectual properties, and other materials located at Marathon's former renewable fuel demonstration facility in Madison, Wisconsin ("Payment-In-Kind Assets").

In May 2025, Bioleum also completed the initial $20 million closing of its Series A preferred equity offering ("Series A Financing"). Bioleum also plans to complete its Series A financing during 2025 and commence project equity and debt financings that includes an allocation of $152 million from the State of Oklahoma in project activity bonds for the construction of its planned first 400,000 barrel per year facility in Oklahoma.

*Strategic Investments Segment*

We own and manage several investments and projects that are strategic to our plans and ability to produce and maximize throughput in our Metals and Mining Segments, that are held for the purpose of complementing or enhancing our mission of accelerating the commercialization of hard technologies for the energy transition and creating value but that are not a component of such other segments or otherwise have distinct operating activities. Our Strategic Investments Segment includes minority equity and equity-linked investments in Green Li-ion Pte Limited (lithium-ion battery component recycler and remanufacturing), RenFuel (advanced biofuel development and production), Hexas (propagation and production of purpose grown energy crops), and Sierra Springs Opportunity Fund (northern Nevada real estate) and other equity investments. In November 2024, we completed a transaction for the disposition of our minority equity investment in GenMat while retaining the rights for using the technologies.

*Investment in Green Li-ion*– Our wholly owned LINICO subsidiary owns 35,662 Green Li-ion preferred shares representing 13.34% of Green Li-ion. The Company intends to sell its remaining shares by the end of 2026.

*Investment in SSOF* – For the six-months ended June 30, 2025, the Company invested an additional $650,000 in SSOF for 361,111 additional common shares at $1.80 per share. At June 30, 2025 and December 31, 2024, the Company owns 11,236,111 and 10,875,000, respectively, of SSOF shares and our ownership is at 17.40% and 17.27%, respectively. At June 30, 2025 and December 31, 2024, no adjustments were made to our investments carrying value as a result of the SSOF equity issuances since the price per share sold was consistent with the Company's carrying value for this investment. At June 30, 2025, the Company's maximum exposure to loss as a result of its involvement with SSOF is limited to its investment of $20,225,000.

SSOF is a qualified opportunity zone fund, that owns 100% of SSE, a qualified opportunity zone business. SSE and its subsidiaries own or controls approximately 2,500 acres of land, a manufacturing facility, significant senior, junior and effluent water rights, sewer rights and also owns and operates the Silver Springs Regional Airport LLC. The substantial majority of these properties are contiguous and strategically located within immediate proximity of Highway 50, State Route 492, the Northern Nevada Industrial Center and the Tahoe Reno Industrial Center where high tech companies like Tesla, Switch, Google, Microsoft, Tract and Redwood Materials, and over one hundred other companies are currently located, expanding or locating in this industrializing region.

*Investment in Hexas* – On January 14, 2025, we executed an agreement with Hexas, under which Hexas agreed to grant the Company an exclusive worldwide license to Hexas' intellectual properties in liquid fuels applications, subject to certain pre-existing agreements and relationships, and to provide certain development services in connection with Bioleum's site development and innovation activities. Through June 30, 2025, the Company invested $765,334 in Hexas in the form of simple agreements for future equity ("Hexas SAFE Investment").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 34

------

[**Table of Contents**](#toc)

*Investment in Research and Development Company*

On March 1, 2024, the Company entered into Securities Purchase Agreement (the "Developer Securities Purchase Agreement") with an unaffiliated research and development company ("Developer") and recognized an initial investment of $1,290,614. Concurrently and in connection with the entity into the Developer Securities Purchase Agreement, the Company and Developer entered into Development Services Agreement ("DSA") for purposes of conducting certain research and development work. At June 30, 2025, the future remaining payments, net implied interest, totaled $1,193,140. During the six-months ended June 30, 2025 and 2024, the Company paid $0 and $180,000, respectively, to the Developer in accordance with the funding commitments under the Developer Securities Purchase Agreement.

***Other***

*Investments in Properties* – The Company directly owns three types of properties in Silver Springs, NV, including 98 acres of industrial land, 160 acres of commercial land, both centrally located in Silver Springs, just south of the Silver Springs Regional Airport and a portfolio of water rights. The Company has begun marketing these assets for sale as both industrial and commercial development as interest in Silver Springs, NV has increased.

COMPARATIVE FINANCIAL INFORMATION

Below we set forth a summary of comparative financial information for the three-months ended June 30, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
|  | **June 30, 2025** | **June 30, 2024** | **Change** |
| Revenue | $339546 | $434824 | $(95278) |
| Cost of goods sold | 814001 |  | 814001 |
| *Operating Expenses:* |  |  |  |
| Selling, general and administrative expenses | 4635090 | 2792822 | 1842268 |
| Research and development | 2120645 | 2548467 | (427822) |
| Depreciation and amortization | 636692 | 656717 | (20025) |
| Gain on sale of mineral rights | (200000) |  | (200000) |
| Total operating expenses | 7192427 | 5998006 | 1194421 |
| Loss from operations | (7666882) | (5563182) | (2103700) |
| *Other Income (Expense)* |  |  |  |
| Interest expense | (774062) | (782440) | 8378 |
| Interest income | 154700 | 65081 | 89619 |
| Change in fair value of derivative instruments | 2868176 | (77496) | 2945672 |
| Loss on conversion of debt | (2133951) | (1278544) | (855407) |
| Loss on debt extinguishment |  | (521622) | 521622 |
| Other income (expense) | (274924) | (494069) | 219145 |
| Total other income (expense), net | (160061) | (3089090) | 2929029 |
| Net loss | (7826943) | (8652272) | 825329 |
| Net loss attributable to noncontrolling interest |  | (18720) | 18720 |
| Net loss attributable to Comstock Inc. | $(7826943) | $(8633552) | $806609 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 35

------

[**Table of Contents**](#toc)

RESULTS OF OPERATIONS

*Three-Months Ended June 30, 2025 Compared to Three-Months Ended June 30, 2024*

Revenues for the three-months ended June 30, 2025 decreased by $95,278 to $339,546 from $434,824 for the comparable 2024 period, primarily attributed to the following:

• Lower revenues from our Mining Segment of $390,175 were attributed to the termination of the Mackay Mining Lease in the fourth quarter of 2024, partially offset by

• Higher revenues from our Metals Segment of $295,397 for our Comstock Metals operations in 2025, primarily for decommissioning services and to a lesser extent, sales of aluminum, glass and mineral-rich tailings, including silver.

Cost of goods sold for the three-months ended June 30, 2025 increased $814,001 primarily due to the commencement of our first commercial demonstration facility operating at far less than full capacity due to the installation of additional air quality control system, all for metal recycling operations.

Revenue and costs of sales in future periods will vary significantly depending on a number of factors, including the amount of solar panels that we recycle and the amount of renewable energy technology solutions that we license and sell, lease revenues on our real properties, the market prices for those services, the extent to which we secure and collect reasonable royalties, the degree to which we can provide event-driven engineering services, and the costs associated with each component of the aforementioned revenues.

Selling, general and administrative expense for the three-months ended June 30, 2025 increased by $1,842,268 to $4,635,090 from $2,792,822 in the comparable 2024 period, primarily as a result of higher employee-related costs of $912,247, primarily due to an adjustment to lower the 2023 accrued incentive compensation of $507,169 in 2024 and a higher number of employees in 2025 as compared to the 2024 period, higher rent expense of $442,127, higher consulting expense of $209,726, higher legal expense of $141,455 and higher marketing expense of $81,063.

Research and development expenses for the three-months ended June 30, 2025 decreased by $427,822 to $2,120,645 from $2,548,467 in the comparable 2024 period, primarily related to lower rent expense of $1,305,199 attributed to the AST research and development rent of $1,208,180 paid in April 2024 (see Note 8 to the condensed consolidated financial statements); partially offset by higher research and development costs for renewable fuel associated projects, substantially all with external laboratories of $561,813 and higher employee-related costs of $252,382.

Depreciation and amortization for the three-months ended June 30, 2025 decreased by $20,025 to $636,692 from $656,717 in the comparable 2024 period, primarily related to higher amortization of intangible assets in the three-month period ended June 30, 2024 that were impaired later in 2024.

In 2025, we recognized a gain on the sale of mineral rights of $200,000 related to the Mackay First Amendment (see Note 5 to the condensed consolidated financial statements).

Interest expense for the three-months ended June 30, 2025 decreased by $8,378 to $774,062 from $782,440 in the comparable 2024 period, primarily due to lower interest and lower amortization of the original issue discount ("OID") on the 2025 Kips Bay Note in 2025 compared to the 2023 Kips Bay Notes in 2024.

Interest income for the three-months ended June 30, 2025 increased by $89,619 to $154,700 from $65,081 in the comparable 2024 period, primarily due to higher accrued interest income related to the RenFuel note receivable.

Change in the fair value of our derivative instruments for the three-months ended June 30, 2025 increased by $2,945,672 to a gain of $2,868,176 from a loss of $77,496 in the comparable 2024 period, resulting from an increase in the Company's share price in connection with potential make whole obligations for minimum value commitments on the Company's common stock and the change in fair value of conversion option derivatives.

Loss of $2,133,951 on the conversion of debt to equity for the three-months ended June 30, 2025 is attributed to the 2025 Kips Bay Note debt conversions. Loss of $1,278,544 on the conversion of debt to equity for the three months ended June 30, 2024 is attributed to the 2023 Kips Bay Note debt conversions.

Loss on debt extinguishment of $521,622 resulted from the debt modifications in 2024 for the Amended GHF 2021 Note and Amended Alvin Fund 2023 Note. No amendments were made to the GHF 2021 Note or Alvin Fund Notes in the first half of 2025.

Other income (expense), net for the three-months ended June 30, 2025 were $274,924, primarily consisting of an unrealized loss on fair value change on the AST receivables of $266,483.

Other income (expense), net for the three-months ended June 30, 2024 were $494,069, primarily consisting of losses from our equity method investments of $649,281 primarily from GenMat losses of $606,935, which was sold in the fourth quarter of 2024; partially offset by other income recognized on SSOF deposits of $400,000.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 36

------

[**Table of Contents**](#toc)

COMPARATIVE FINANCIAL INFORMATION

Below we set forth a summary of comparative financial information for the six-months ended June 30, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
|  | **June 30, 2025** | **June 30, 2024** | **Change** |
| Revenue | $1125361 | $860775 | $264586 |
| Cost of goods sold | 1700797 |  | 1700797 |
| *Operating Expenses:* |  |  |  |
| Selling, general and administrative expenses | 7893555 | 6320346 | 1573209 |
| Research and development | 5424563 | 3440480 | 1984083 |
| Depreciation and amortization | 1012076 | 1312695 | (300619) |
| Gain on sale of mineral rights | (200000) |  | (200000) |
| Total operating expenses | 14130194 | 11073521 | 3056673 |
| Loss from operations | (14705630) | (10212746) | (4492884) |
| *Other Income (Expense)* |  |  |  |
| Interest expense | (1433206) | (1601102) | 167896 |
| Interest income | 250809 | 139573 | 111236 |
| Change in fair value of derivative instruments | 1677373 | (833614) | 2510987 |
| Loss on conversion of debt | (3330831) | (1472067) | (1858764) |
| Gain on extinguishment of liability | 845000 |  | 845000 |
| Loss on debt extinguishment |  | (521622) | 521622 |
| Other income (expense) | (224389) | (1069014) | 844625 |
| Total other income (expense), net | (2215244) | (5357846) | 3142602 |
| Net loss | (16920874) | (15570592) | (1350282) |
| Net loss attributable to noncontrolling interest |  | (35628) | 35628 |
| Net loss attributable to Comstock Inc. | $(16920874) | $(15534964) | $(1385910) |

---

RESULTS OF OPERATIONS

*Six-Months Ended June 30, 2025 Compared to Six-Months Ended June 30, 2024*

Revenues for the six-months ended June 30, 2025 increased by $264,586 to $1,125,361 from $860,775 for the comparable 2024 period, primarily attributed to the following:

• Higher revenues from our Metals Segment of $1,044,162 for our Comstock Metals operations in 2025, primarily for decommissioning services and to a lesser extent, sales of aluminum, glass and mineral-rich tailings, including silver; partially offset by

• Lower revenues from our Mining Segment of $781,251 were attributed to the termination of the Mackay Mining Lease in the fourth quarter of 2024. 

Cost of goods sold for the six-months ended June 30, 2025 increased $1,700,797 primarily due to the commencement of our first commercial demonstration facility operating at far less than full capacity due to the installation of additional air quality control system, all for metal recycling operations.

Revenue and costs of sales in future periods will vary significantly depending on a number of factors, including the amount of solar panels that we recycle and the amount of renewable energy technology solutions that we license and sell, lease revenues on our real properties, the market prices for those services, the extent to which we secure and collect reasonable royalties, the degree to which we can provide event-driven engineering services, and the costs associated with each component of the aforementioned revenues.

Selling, general and administrative expense for the six-months ended June 30, 2025 increased by $1,573,209 to $7,893,555 from $6,320,346 in the comparable 2024 period, primarily as a result of higher rent expense of $792,442, higher consulting expense of $374,994, higher legal fees of $253,311 and higher marketing expense of $208,378.

Research and development expenses for the six-months ended June 30, 2025 increased by $1,984,083 to $5,424,563 from $3,440,480 in the comparable 2024 period, primarily related to higher research and development costs for renewable fuel associated projects, substantially all with external laboratories of $1,144,384, higher employee-related costs of $469,583, higher consulting expense of $177,635 and higher rent expense of $151,438 attributed to the AST research and development rent of $1,487,476 paid in March 2025 as compared to $1,208,180 paid in April 2024 (see Note 8 to the condensed consolidated financial statements).

Depreciation and amortization for the six-months ended June 30, 2025 decreased by $300,619 to $1,012,076 from $1,312,695 in the comparable 2024 period, primarily related to higher amortization of intangible assets in the six-month period ended June 30, 2024 that were impaired later in 2024.

In 2025, we recognized a gain on the sale of mineral rights of $200,000 related to the Mackay First Amendment (see Note 5 to the condensed consolidated financial statements).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37

------

[**Table of Contents**](#toc)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest expense for the six-months ended June 30, 2025 decreased by $167,896 to $1,433,206 from $1,601,102 in the comparable 2024 period, primarily due to lower interest and lower amortization of the OID on the 2025 Kips Bay Note in 2025 compared to the 2023 Kips Bay Notes in 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest income for the six-months ended June 30, 2025 increased by $111,236 to $250,809 from $139,573 in the comparable 2024 period, primarily due to higher accrued interest income related to the RenFuel note receivable.

Change in the fair value of our derivative instruments for the six-months ended June 30, 2025 increased by $2,510,987 to a gain of $1,677,373 from a loss of $833,614 in the comparable 2024 period, resulting from an increase in the Company's share price in connection with potential make whole obligations for minimum value commitments on the Company's common stock and the change in fair value of conversion option derivatives.

Loss of $3,330,831 on the conversion of debt to equity for the six-months ended June 30, 2025 is attributed to the 2025 Kips Bay Note debt conversions. Loss of $1,472,067 on the conversion of debt to equity for the six months ended June 30, 2024 is attributed to the 2023 Kips Bay Note debt conversions.

Gain on extinguishment of liability of $845,000 was attributed to the restructuring of the LINICO acquisition-related payable (see Note 12 to the condensed consolidated financial statements).

Loss on debt extinguishment of $521,622 resulted from the debt modifications in 2024 for the Amended GHF 2021 Note and Amended Alvin Fund 2023 Note. No amendments were made to the GHF 2021 Note or Alvin Fund Notes in the first half of 2025.

Other income (expense), net for the six-months ended June 30, 2025 were $224,389, primarily consisting of an unrealized loss on fair value change on the AST receivables of $266,483.

Other income (expense), net for the six-months ended June 30, 2024 were $1,069,014, primarily consisting of losses from our equity method investments of $1,225,185 primarily from GenMat losses of $1,173,139, which was sold in the fourth quarter of 2024; partially offset by other income recognized on SSOF deposits of $400,000.

OUTLOOK

Our goal is to *Accelerate the Commercialization of Breakthrough Technologies.* Comstock innovates and commercializes technologies, systems and supply chains that extract, integrate and convert under-utilized waste and natural resources into clean energy products, including pioneering technologies that produce electrification metals from end-of-life electronics, and investments, like Green Li-Ion, that produces electrification products from recycled electrification waste and Bioleum, that produces renewable fuels from waste, purpose grown energy crops and other forms of woody biomass.

We are pushing the boundaries of what is possible in technology and sustainability by leveraging our teams' unique skills, our investments and the related diverse technology portfolios and our frontier research and development networks toward achieving breakthrough innovations that deliver meaningful positive impact across industries, economies and communities. The primary focus for 2025 is the commercialization of Comstock Metals and the continuous innovation, development and engineering of technologies and solutions, by us and by our partners, that support the efficient conversion of these resources into clean, profitable energy products.

*Corporate* 

The growth opportunities for both Comstock Metals and Bioleum have developed well beyond our original plans, and we have attracted some of the most sophisticated partners for investment, feedstock, technology, operations, and offtake, with many now evaluating or having already direct investments and that are exploring deeper integrations and strategic transactions.

During the first quarter, the Company's authorized share capacity was properly repositioned for more effectively and substantively capitalizing on these opportunities, while in the meantime, both Bioleum and Green Li-ion have successfully completed their own independent direct fundings using their own equity on terms that are non-dilutive to common stock of the Company. These self-funding activities with keenly strategic capital partners, enabling the Company to solidify its own capital base, unlock the value in each of its businesses and investments, and extend the functionality of its system for tremendous growth potential.

On February 24, 2025, the Company increased its authorized capital capacity by implementing a 1:10 reverse stock split, without a corresponding decrease in the existing 245,000,000 authorized shares, effectively increasing the Company's authorized capital resources with sufficient available authorized shares of common stock that positions the right capital sources, liquidity, and profile that we believe has already begun attracting more of the right amounts and types of capital resources needed to grow the Company's value.

The Company's Corporate objectives for the rest of 2025 include:

• Monetize our legacy real estate and non-strategic investments for over $50 million;

• Support the next phases of Metals growth; and

• Finalize, communicate and implement plans to unlock maximum value from the separation of Bioleum.

This ultimately results in two high-growth companies: a renewable metals and mining company headquartered in Nevada, and a renewable fuels company headquartered in Oklahoma and with major operations already functioning in Wisconsin.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38

------

[**Table of Contents**](#toc)

*Comstock Metals*

Comstock Metals has now been operating its first commercial demonstration facility for nearly 18 months and in November of 2024, submitted permits for the first industry-scale photovoltaic recycling facility. The industry-scale facilities are anticipated to ultimately operate at least 100,000 tons of annual capacity. Site selection activities are ongoing for the next two industry-scale facilities and associated storage sites. The Company plans to ultimately build up to 7 industry-scale U.S. based recycling facilities.

The Company's Metals objectives for the rest of 2025 include:

• Maximize three-shift production and revenue from the demonstration scale production facility;

• Secure sufficient funding for scale-up of the first Nevada site to industry-scale;

• Expand local county storage capacity adjacent to our first industry-scale facility;

• Complete permitting for our first industry-scale facility in Silver Springs, NV;

• Procure, deploy, and assemble plant and equipment for our first industry-scale facility in Silver Springs, NV;

• Secure additional Master Service Agreements (MSA) with national and regional customers;

• Complete site selection and preliminary development for two additional solar panel recycling locations; 

• Expand the system globally with international strategic and capital partners.

• Advance R&D efforts to recover more and higher-purity materials from recycled streams for offtake; and

• Closing on equity and/or debt financing that accelerates the deployment of the first three industry facilities.

The capital expenditures for the first 100,000 tons of annual capacity for the first industry scale facility are expected to be approximately $12.0 million which includes expanded storage. In 2025, approximately $10.0 million of capital expenditures are expected to be made with additional up to $2.0 million, spent in the first half of 2026. Billable revenues are expected to be eight times greater in 2025, as compared to 2024, or over $3.5 million, with proportionate future increases in 2026, as we scale up our first industry-scale facility.

*Comstock Mining*

Comstock Mining has amassed the single largest known repository of historical and current geological data within the Comstock mineral district, including extensive geophysical surveys, geological mapping, and drilling data, including the Dayton resource.

The Company's Mining objectives for the rest of 2025 include:

• Receive cash proceeds of over $2.0 million from prior mineral leases and asset sales from the northern claims;

• Commercialize agreements that either monetize or enable resource expansion of the central claims; and

• Complete the preliminary mine plans that enable the economic development of the southern district claims.

The Company's 2025 efforts will apply economic analysis to Comstock's existing gold and silver resources progressing toward preliminary economic feasibility for the southern part of the district and the ultimate development of full mine and reclamation plans and the development of post productive land and community development plans.

*Bioleum*

Bioleum's biorefining technologies are commercially ready for deployment and offer growth-enabling performance. Bioleum is actively engaged in the planning and deployment of its first commercial demonstration facility and pursuing joint development and licensing agreements representing future revenue sources from technical and engineering services, royalties, and equity participation. These efforts include securing associated supply chain participants (including feedstock, site selection, engineering, construction and procurement, and offtake), performing preliminary and final engineering, and facilitating commissioning, construction, and operations, including with globally and locally recognized current and developing renewable fuels producers that, in certain cases, also represent a source of strategic capital for funding the projects.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bioleum's objectives for the rest of 2025 include:

• Stand up a separate, stand-alone, well-capitalized, renewable fuels business through a directly financed separation of Bioleum entity that is solely focused on advancing our objective of delivering hundreds of millions of barrels by 2035 and a public offering;

• Close on subsidiary-level "Series A" equity financing in the separate Fuels entity;

• Plan and integrate a local, Hexas-based, fuel farm based into our first commercial biorefinery;

• Complete site selection for first commercial biorefinery project in Oklahoma, including feedstock and offtake;

• Secure sufficient project-level financing for first Oklahoma-based commercial biorefinery project;

• Execute additional revenue generating licenses and other commercial agreements; 

• Expand integrated pilot production capabilities to up to two barrels per week of intermediates and fuels; and

• Advance our innovation and development efforts toward even higher yields, lower costs and lower capital.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bioleum's commercialization plans also include multiple joint development projects, with each joint development project, such as Bioleum's SACL and other licensees, with the potential for generating hundreds of millions of dollars per year in technical services, engineering, and licensing revenues. Comstock Fuels also offers integrations of its solutions into existing agriculture, forestry, pulp and paper, ethanol, and petroleum infrastructure to generate additional technical services, engineering and royalty revenues. The plans also include integrating Bioleum's high yield Bioleum refining platform with Hexas' high yield energy crops to provide enough feedstock to produce upwards of 100 barrels of fuel per acre per year, effectively transforming agricultural lands into perpetual "drop-in sedimentary oilfields" with the potential to dramatically boost domestic and global energy independence.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 39

------

[**Table of Contents**](#toc)

**Strategic Investments**

*Investment in Green Li-ion*

Green Li-ion continues making meaningful progress in the development and deployment of its system that remanufactures critical precursor cathode active materials ("PCAM"), having now deployed its first commercial battery remanufacturing facility from fully recycled battery materials deployed. The Company intends to sell the remaining 35,662 Green Li-ion preferred shares in 2026.

*Investments in others non-mining real estate, water rights and securities*

The Company has announced plans for selling its non-mining real estate and water rights anticipated in the latter part of 2026.

LIQUIDITY AND CAPITAL RESOURCES

Our financial position and liquidity are based on our net sources of capital from financing as generally compared to our net uses of capital from investing activities and ultimately, our ability to provide or use cash flows from or in our operations. Our cash balances at June 30, 2025 and December 31, 2024 were $18,587,742 and $954,271, respectively, with $17,758,282 representing Bioleum's total cash balance at June 30, 2025. The Company had current assets of $22,992,943 and current liabilities of $15,360,843, representing working capital excess of $7,632,100 at June 30, 2025.

The current liabilities include $4,291,849 of accrued expenses, including $940,529 for the payable to a research and development company, $952,538 for further investment into Bioleum through the committed Flux payments, $1,168,282 for accrued payroll and related expenses and $431,250 for incentive compensation.

The Company intends to fund our operations over the next twelve months from revenues from our solar panel recycling business, issuance of equity under our existing shelf registration statement, issuances of debt, sales of non-strategic assets and other investments, and existing cash and cash equivalents. Based on these expected funding sources, management believes we will have sufficient funds to sustain our operations and meet our commitments under our investment agreements during the 12 months following the date of issuance of the condensed consolidated financial statements included herein. While we have been successful in the past in obtaining the necessary capital to support our operations, including registered equity financings from our existing shelf registration statement, non-registered equity placements, non-registered equity issued directly from certain investments, government grants, borrowings, and various other means, there is no assurance we will be able to obtain additional equity capital or other financing, if needed.

Our primary source of liquidity during the first six-months of 2025 was cash from financing activities. During the six-months ended June 30, 2025, we generated $31,231,350 in cash from our financing activities and we used $9,779,185 and $3,818,694, respectively, in cash in our operating and investing activities. Our primary source of liquidity during the first six-months of 2024 was cash from financing activities. During the six-months ended June 30, 2024, we generated $6,823,459 in cash from our financing activities and we used $5,830,794 and $4,663,938, respectively, in cash in our operating and investing activities.

The Company continues commercializing its metals recycling lines of business. Comstock Metals has filed permits and expects to build and commission its first industry scale facility during early 2026, with a capacity up to 100,000 tons of processed material per year, for up to $12 million, including expanding its existing storage capacity. The first industry scale facility will also be funded by additional equity and debt, including direct term loans or industrial bonds and/or other alternative qualified loan financings. Comstock Metals expects to have at least three industry scale facilities operating with up to 100,000 tons of annual capacity coming online over the next three years (2026 through 2028), with up to four additional industry-scale facilities and expansions and strategically located storage areas also being planned across the U.S. markets.

The Company has increasing access to a number of alternative capital resources, including a new $50 million shelf registration statement filed in March 2025, $20 million in proceeds to date from the Bioleum Preferred Series A offering, $152 million in allocated project activity bonds from the State of Oklahoma, various grant sources, including a recent $3.0 million grant from the State of Oklahoma, various planned asset sales in 2025 and 2026. The Company is also planning additional "Series A" direct equity investment into Bioleum during 2025, from various known strategic and other investors directly into Bioleum.

On August 8, 2025, the Company reached agreement amend its outstanding promissory notes with its creditors, Georges Trust and Alvin Fund LLC. Pursuant to the amendments, the Company issued 2,900,000 shares to such creditors, the proceeds of which will be used by such creditors to pay the $8,390,000 principal amount and interest owed to such creditors. Pursuant to the amendments, on or before April 15, 2026, the Company is required to pay such creditors an amount equal to the total amounts payable pursuant to the promissory notes minus the net cash proceeds received the creditors from the sale of the Company's commons shares. Any cash proceeds or shares held after repayment of the promissory notes shall be returned to the Company. The Company is required to file a resale registration statement for the benefit of the creditors.

On August 12, 2025, the Company announced a Confidentially Marketed Public Offering ("CMPO") with Titan Partners. The Company raised $30 million in gross proceeds before underwriting discounts and commissions and other offering expenses. The Company plans on using the net proceeds from this offering to make (i) a final capital contribution to Northern Comstock in an amount of $1,412,500, (ii) a $2,500,000 cash payment to Kips Bay on or before August 19, 2025, (iii) up to $12 million for capital expenditures for the Comstock Metals first industry scale facility, and other related operating and development expenses associated with commercializing that first industry scale facility and the rest for general corporate purposes.

On January 10, 2025, the Company entered into a securities purchase agreement ("2025 Kips Bay Agreement") for an unsecured convertible promissory note (the "2025 Kips Bay Note") with Kips Bay Select, L.P. ("Kips Bay") with a principal amount of $10,638,298, of which $5,000,000 was funded in cash on January 13, 2025 and the remaining $5,000,000 funded on March 11, 2025 with an original issue discount of $638,298. The full principal is due on April 10, 2026. Interest is payable monthly at a rate of 6% per annum. As of August 12, 2025, the remaining principal balance on the 2025 Kips Bay Note was $2,200,000.

On August 12, 2025, the Company entered into a payoff letter agreement (the "Payoff Agreement"), with Kips Bay related to the Company's obligations under the 2025 Kips Bay Note in the original aggregate principal amount of $10,638,298. Pursuant to the Payoff Agreement, Kips Bay agreed to accept the payment of $2,500,000 in cash from the proceeds and the issuance of 447,724 shares of Common Stock, previously reserved and approved for issuance upon conversion of the Note (the "Payoff Shares"), in full satisfaction of the Company's obligations under the Note.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 40

------

[**Table of Contents**](#toc)

Risks to our liquidity could result from future operating expenditures above management's expectations, including but not limited to pre-development, research and development, exploration, selling, general and administrative, and investment related expenditures in excess of sale proceeds from our non-strategic assets and other investments, amounts to be raised from direct equity from our subsidiaries or the issuance of equity under our existing shelf registration statement or amounts to be raised directly from the non-registered equity of our subsidiaries, declines in the market value of properties planned for sale, or declines in the share price of our common stock that would adversely affect our results of operations, financial condition and cash flows. If we were unable to obtain any necessary additional funds, this could have an immediate material adverse effect on liquidity and raise substantial doubt about our ability to continue as a going concern. In such case, we could be required to limit or discontinue certain business plans, activities or operations, reduce or delay certain capital expenditures or investments, or sell certain assets or businesses. There can be no assurance that we would be able to take any such actions on favorable terms, in a timely manner, or at all.

CRITICAL ACCOUNTING ESTIMATES

There have been no significant changes to the critical accounting estimates disclosed in Management's Discussion and Analysis of Financial Condition and Results of Operations in our 2024 Form 10-K.

**ITEM 3** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

*Market Prices*

Changes in the market price of commodities, including precious metals, critical metals and oil and gas may significantly affect our future profitability and cash flow. Metal and fuel prices fluctuate widely due to factors such as: demand, global production levels, supply chain constraints, investor sentiment, central bank reserves, global conflicts and the value of the U.S. dollar and other currencies.

*Interest Rate Risk*

The interest rates on our existing long-term debt borrowings are fixed, and as a result, interest due on borrowings are not impacted by changes in market-based interest rates.

There have been no material changes in the market risks discussed in Item 7A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

**ITEM 4** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **CONTROLS AND PROCEDURES**

***A. Disclosure***

*Evaluation of Disclosure Controls and Procedures*

As of the end of the period covered by this Quarterly Report on Form 10-Q, with the participation of our Principal Executive Officer and Principal Financial Officer, an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 ("Exchange Act") was conducted. Our disclosure controls and procedures are designed to ensure information required to be disclosed in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Exchange Act rules, and such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, to allow timely decisions regarding required disclosures. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based on that evaluation, our chief executive officer concluded that our disclosure controls and procedures, including controls and procedures designed to ensure that information required to be disclosed by us is accumulated and communicated to our management, were effective as of June 30, 2025, in assuring them in a timely manner that material information required to be disclosed in this report has been properly recorded, processed, summarized and reported.

*Changes in Internal Control Over Financial Reporting* 

During the quarter ended June 30, 2025, there was no change in our internal control over financial reporting that materially affected or is reasonably likely to materially affect our internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 41

------

[**Table of Contents**](#toc)

**PART II - OTHER INFORMATION**

**ITEM 1** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **LEGAL PROCEEDINGS**

The Company's metals, mining and related activities are subject to various laws and regulations governing environmental protection. These laws and regulations are frequently changing and generally becoming more restrictive. The Company believes its operations comply with applicable laws and regulations, in all material respects. The Company continuously makes expenditures to comply with such laws and regulations but cannot predict the full amount of such future expenditures.

From time to time, we are involved in claims and proceedings that arise in the ordinary course of business. There are no matters pending that we expect to have a material adverse impact on our business, results of operations, financial condition or cash flows.

**ITEM 1A** &nbsp;&nbsp;&nbsp;&nbsp; **RISK FACTORS**

No new risk factors have been identified in addition to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024.

**ITEM 2** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **UNREGISTERED SALES OF EQUITY SECURITIES AND USES OF PROCEEDS**

During the three-months ended June 30, 2025, pursuant to the 2025 Kips Bay Note, the Company issued 2,629,601 shares of the Company's common stock to Kips Bay with a fair value of $6,738,499 at an average conversion price of $2.56.

On June 12, 2025, the Company issued 200,000 shares of unregistered restricted shares of its common stock with a fair value of $700,000 to Decommissioning Services in accordance with the Amended Agreement.

On June 10, 2025, the Company issued 2,000,000 shares of unregistered restricted shares of its common stock with a fair value of $5,780,000 to Flux Photon Corporation and affiliates in accordance with the Amendment to the FPC Asset Purchase Agreement.

On June 9, 2025, the Company issued 33,465 shares of unregistered restricted shares of its common stock with a fair value of $80,658 to Alvin Fund LLC in lieu of payment of interest under the Alvin Fund 2022 Note.

On May 13, 2025, the Company executed subscription agreements with two investors for private placement and issued 625,000 shares of unregistered restricted shares of its common stock for $1,500,000.

On May 5, 2025, the Company issued 24,228 shares of unregistered restricted shares of its common stock with a fair value of $61,447 to Alvin Fund LLC in lieu of payment of interest under the Alvin Fund 2023 Note.

**ITEM 3** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **DEFAULTS UPON SENIOR SECURITIES**

None.

**ITEM 4** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **MINE SAFETY DISCLOSURES**

Pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 104 of Regulation S-K, we are required to disclose items believed to be violations of the Federal Mine Safety and Health Act of 1977, any health and safety standard, or any regulation, as administered by the Federal Mine Safety and Health Administration. The required information is included in Exhibit 95 to this Report on Form 10-Q.

**ITEM *5*** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **OTHER INFORMATION**

During the quarter ended *June 30, 2025*, no director or officer of the Company adopted or terminated any contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of "Rule *10b5*-*1* trading arrangement" or any "non-Rule *10b5*-*1* trading arrangement," as those terms are defined in Regulation S-K, Item *408.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 42

------

[**Table of Contents**](#toc)

**ITEM 6** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **EXHIBITS**

The exhibits required to be filed as a part of this Report on Form 10-Q are listed in the Exhibit Index attached hereto, which is incorporated herein by reference.

(1) Exhibits filed as part of this Report:

See Exhibits for which the Exhibit number is noted with an asterisk on the Exhibit Index attached hereto.

---

| | |
|:---|:---|
| **Exhibit**<br> **Number** | **Exhibit** |
| 10.1 | [Employment Agreement (incorporated by reference to Exhibit 10.1 on Form 8-K filed May 15, 2025).](http://www.sec.gov/Archives/edgar/data/1120970/000143774925017218/ex_819221.htm) |
| 10.2 | [Assignment Agreement (incorporated by reference to Exhibit 10.1 on Form 8-K filed May 28, 2025).](http://www.sec.gov/Archives/edgar/data/1120970/000143774925018680/ex_823310.htm) |
| 10.3 | [Investor's Rights Agreement (incorporated by reference to Exhibit 10.2 on Form 8-K filed May 28, 2025).](http://www.sec.gov/Archives/edgar/data/1120970/000143774925018680/ex_823198.htm) |
| 10.4 | [Voting Agreement (incorporated by reference to Exhibit 10.3 on Form 8-K filed May 28, 2025).](http://www.sec.gov/Archives/edgar/data/1120970/000143774925018680/ex_823199.htm) |
| 10.5 | [Right of First Refusal Agreement (incorporated by reference to Exhibit 10.4 on Form 8-K filed May 28, 2025).](http://www.sec.gov/Archives/edgar/data/1120970/000143774925018680/ex_823200.htm) |
| 10.6 | [Management Services Agreement (incorporated by reference to Exhibit 10.5 on Form 8-K filed May 28, 2025).](http://www.sec.gov/Archives/edgar/data/1120970/000143774925018680/ex_823781.htm) |
| 10.7 | [Amendment to Asset Purchase Agreement (incorporated by reference to Exhibit 10.6 on Form 8-K filed May 28, 2025).](http://www.sec.gov/Archives/edgar/data/1120970/000143774925018680/ex_823311.htm) |
| 10.8 | [First Amendment to Membership Interest Purchase Agreement (incorporated by reference to Exhibit 10.1 on Form 8-K filed June 9, 2025).](http://www.sec.gov/Archives/edgar/data/1120970/000143774925019869/ex_828408.htm) |
| 10.9 | [Third Amendment to Lease with Option to Purchase Agreement (incorporated by reference to Exhibit 10.2 on Form S-3 filed June 18, 2025).](http://www.sec.gov/Archives/edgar/data/1120970/000143774925020787/ex_829461.htm) |
| 31.1\* | [<u>Certification of Principal Executive Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.</u>](ex_815981.htm) |
| 31.2\* | [<u>Certification of Principal Executive Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.</u>](ex_826127.htm) |
| 32.1\* | [<u>Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</u>.](ex_815982.htm) |
| 32.2\* | [<u>Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</u>.](ex_826128.htm) |
| 95\* | [<u>Mine Safety Disclosures</u>.](ex_815983.htm) |
| 101\* | Interactive Data File (Quarterly Report on Form 10-Q, for the periods ended June 30, 2025, furnished in iXBRL (Inline eXtensible Business Reporting Language)).<br>Attached as Exhibit 101 to this report are the following documents formatted in XBRL: (i) the Condensed Consolidated Balance Sheets at June 30, 2025 and December 31, 2024, (ii) the Condensed Consolidated Statements of Operations for the three and six-months ended June 30, 2025 and 2024, (iii) the Condensed Consolidated Statements of Changes in Equity for the three and six-months ended June 30, 2025 and 2024, (iv) the Condensed Consolidated Statements of Cash Flows for six-months ended June 30, 2025 and 2024 and (v) the Notes to Condensed Consolidated Financial Statements, tagged as blocks of text. Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections. |
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document contained in Exhibit 101 |

---

\* Filed herewith.

# Management contract or compensatory plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 43

------

[**Table of Contents**](#toc)

**The SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the date indicated.

---

| |
|:---|
| COMSTOCK INC. |
| By: /s/ CORRADO DE GASPERIS |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CORRADO DE GASPERIS |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Executive Chairman |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chief Executive Officer |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Principal Executive Officer) |
| Date: August 14, 2025 |

---

---

| |
|:---|
| By: /s/ JUDD MERRILL |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;JUDD MERRILL |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chief Financial Officer |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Principal Financial Officer) |
| Date: August 14, 2025 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 44

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, CORRADO DE GASPERIS, certify that:

---

| | | |
|:---|:---|:---|
| 1. | I have reviewed this quarterly report on Form 10-Q of Comstock Inc.; | I have reviewed this quarterly report on Form 10-Q of Comstock Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: | The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|  | a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|  | b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|  | c. | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|  | d. | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting. |
| 5. | The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): | The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
|  | a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|  | b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |

---

---

| |
|:---|
| <u>By: /s/ CORRADO DE GASPERIS</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CORRADO DE GASPERIS |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Executive Chairman |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chief Executive Officer |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Principal Executive Officer |
| August 14, 2025 |

---

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, JUDD MERRILL, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Comstock Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| <u>By: /s/ JUDD MERRILL</u> |
| JUDD MERRILL |
| Chief Financial Officer |
| Principal Financial Officer |
| August 14, 2025 |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION OF PERIODIC REPORT**

In connection with the Quarterly Report on Form 10-Q of Comstock Inc. (the "Company") for the period ended June 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Corrado De Gasperis, Executive Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C 78m(a) or 78o(d)); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| <u>/s/ Corrado De Gasperis</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corrado De Gasperis |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Executive Chairman and Chief Executive Officer (Principal Executive Officer) |

---

Date: August 14, 2025

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION OF PERIODIC REPORT**

In connection with the Quarterly Report on Form 10-Q of Comstock Inc. (the "Company") for the period ended June 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Judd Merrill, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C 78m(a) or 78o(d)); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| <u>/s/ Judd Merrill</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Judd Merrill |
| Chief Financial Officer (Principal Financial Officer) |

---

Date: August 14, 2025

## Ex-95

**Exhibit 95**

The following disclosures are provided pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K, which requires certain disclosures by companies required to file periodic reports under the Securities Exchange Act of 1934, as amended, that operate mines regulated under the Federal Mine Safety and Health Act of 1977 (the "Mine Act").

Whenever the Federal Mine Safety and Health Administration ("MSHA") believes that a violation of the Mine Act, any health or safety standard, or any regulation has occurred, it may issue a citation or order which describes the violation and fixes a time within which the operator must abate the violation. In some situations, such as when the MSHA believes that conditions pose a hazard to persons, MSHA may issue an order requiring removal of persons from the area of the mine affected by the condition until the hazards are corrected. Whenever MSHA issues a citation or order, it has authority to propose a civil penalty or fine, as a result of the violation.

The table below reflects citations and orders issued by MSHA during the six months ended June 30, 2025.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Mining**<br> **Operating**<br> **Name MSHA**<br> **Identification**<br> **Number** | **Section**<br> **104S&S Citations** | **Section**<br> **104(b)**<br> **Orders** | **Section**<br> **104(d)**<br> **Citations**<br> **and**<br> **Orders** | **Section**<br> **110(b)(2) Violations** | **Section**<br> **107(a)**<br> **Orders** | **Received**<br> **Notice of**<br> **Potential**<br> **to Have**<br> **Pattern of Violations**<br> **Under**<br> **Sections**<br> **104(3)** | **Legal**<br> **Actions Pending**<br> **as of**<br> **Last Day**<br> **of Period** | **Legal**<br> **Actions Initiated During**<br> **Period** | **Legal Actions Resolved During Period** |
| 26-01871 | – |  | – |  | – $– – No | No | – |  |  |
| 26-02771 | – |  | – |  | – $– – No | No | – |  |  |

---